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 A PtCl2-catalyzed cycloisomerization, thermal rearrangement, and 
rhodium(I)-catalyzed rearrangement reactions of 1,6-enynes led to 
the construction of various molecular structures. In these reactions, 
1-aryl-tetrahydro-1H-indenes, 3-methylene-4-vinylcyclohex-
1-enes, and aryl-hexahydoisoquinolines are generated from 1,6-
enynes: Depending upon the substituent(s) and tether group of the 
enynes, the PtCl2-catalyzed cycloisomerization products, 
bicyclo[4.1.0]hept-2-enes, undergo vinylcyclopropanes-






























 Bicyclo[4.1.0]hept-2-ene derivatives are a class of the products 
which can be readily obtained by transition metal-catalyzed 
cycloisomerization.[1] They have synthetic potential originated from 
their unique structure. They are very stable even at high 
temperature but they have a strained cyclopropane ring connected to 
cyclohexene which can be easily broken to give rise to another 
sequential rearrangement if it has a substituent(s) activating the 
rupture of cyclopropane ring. Moreover, the geometry of the 
products can be controlled by restricted frame of 
bicyclo[4.1.0]heptenes. Despite of their synthetic potential, their 
use in the organic synthesis of more complex compounds is still 
quite rare. The scarcity of their use in organic synthesis stimulated 
us to explore the possible utilization of bicyclo[4.1.0] heptenes in 
organic synthesis.[2] 
 Among various transition metals catalyzing the transformation of 
bicyclization of 1,6-enynes, we chose platinum dichloride as 
catalyst because it is very stable in air and moisture, and there is no 
need to generate catalyst or to synthesize ligands. The first example 
of formation of bicylo[4.1.0]heptenes by platinum-catalyzed 
cycloisomerization of 1,6-enyne was reported in 1995 by Blum and 
coworkers [Eq.(1)].[3] They reported PtCl4-catalyzed 
cycloisomerization of allyl propargyl ether into 3-
oxabicyclo[4.1.0]heptenes, but mechanistic rationale was not 
provided at that time. In 2000, Fürstner[4] found that PtCl2 is an 
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effective catalyst for transformation of nitrogen tethered 1,6-
enynes to the corresponding 3-azabicyclo[4.1.0]heptenes [Eq. (2)]. 
Using computational methods, Soriano et al[5] proposed the 















































Scheme 1. Proposed mechanism for the Pt catalyzed formation of 
bicyclo[4.1.0]heptene 
 Based on the previous studies, we envisioned that PtCl2 catalyzed 
cycloisomerization of modified enynes would lead to 
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bicyclo[4.1.0]heptenes and subsequently rearranged products 
depending upon the substituents (Scheme 2). Tandem reactions 
have advantages of that unexpected complex molecular structures 
can be generated by combining common reactions. This approach 
might improve a scope of reactions or provide methods for structural 















































cheme 2. Platinum catalyzed cycloisomerization, thermal rearrangement and 
RhI catalyzed rearrangement of 1,6-enynes. 
 
 First, we found that bicyclo[4.1.0]hept-2-ene derivatives can 
selectively undergo a [1,5]hydrogen shift, or a vinylcyclo-propane 
rearrangement depending upon the substituent(s) and tether group 
in the enynes substrates. As these reactions take place with high 
stereochemical fidelity, a wide variety of cyclic and acyclic products 
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containing several sterocenters could be obtained.  
The syntheses of 1-aryl-tetragydro-1H-indenes and 3-
methylene-4-vinylcyclohex-1-enes were achieved through this 
strategy. 
These observations urged us to study a transformation of 
bicyclo[4.1.0]heptenes bearing cyclopyopyl and aryl groups in 1- 
and 6-positions, respectively, which usually had no reactivity 
toward transition metal catalyst.[6f] However, we recently found that 
they were activated in the presence of cationic rhodium compounds 
to give a new cyclization product, aryl-hexahydorisoquiniline. 
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Result and Discussion 
 
1. Thermal rearrangement reaction of Bicyclo[4.1.0]heptenes. 
We initially studied a PtCl2-cattalyzed reaction of oxygen-tethered 
enynes bearing an aryl group at the terminal position of the alkene. 
A (E)-(3-(3-cyclohexenylprop-2-ynyloxy)prop-1-
enyl)benzene 1 was treated with 1.3 mol% PtCl2 in toluene at 80℃ 
for 2 h, a cyclopropanated 1a instead of a dienal[7] was isolated in 
69% yield. Heating the isolated 1a in toluene at 110℃ for 12 h 
without catalyst result in 9-phenyloctahydroindeno[2,1-c]pyran 1b 






The second thermal rearrangement is probably conceived of as a 
vinylcyclopropanes-cyclopentene rearrangement. It has been 
reported[8a-8b] that aryl substituents at alkene moiety influence 
largely on the thermal rearrangement of vinylcyclopropanes.  
 We investigated a consecutive reaction of PtCl2-catalysed 
cycloisomerization and thermal reaction in a one-pot reaction. When 
the same reaction was carried out at 120℃, the total yield was 
improved to 80%. We further screened the consecutive reactions of 




















rearrangement with a variety of dienynes having a phenyl group at 
the terminal carbon of an alkene moiety. The results are compiled in 
Table 1.  
Table 1. A consecutive reaction of PtCl2-catalyzed cycloisomerization and 
vinylcyclopropane rearrangement[a]  





  X Ar R   
1 1 O Ph H 18 1b (80) 
2 2 NTs Ph H 24 2b (80) 
3 3 O Ph Me 24 3b (34) 
4 4 NTs p-CH3OC6H4 H 24 4b (68) 
5 5 NTs p-CH3C6H4 H 24 5b (74) 
 
  
  R1 R2 R3   
6 6 H H Me 22 6b (59) [c] 
7 7 H Me Me 24 7b (36) [d] 
8 8 Ph Ph H 18 8b (57) 
9 9 H Ph H 3 9b (48) [e] 
 [a] Reaction conditions: 0.3 mmol of substrate and 5 mol% PtCl2 were reacted in 6 mL 
toluene at 120℃. [b] Isolated yield. [c] Isolated as a mixture with 6 in 10% yield. [d] Isolated 
as a mixture with 7 in 36% yield. [e] Isolated as a mixture with 9 in 19% yield. 
As the table shows, the reactants gave the expected products in 
reasonable to high yield (36%-80%). The best yield was obtained 
when a nitrogen or an oxygen tethered enyne having a cyclohexene 
moiety was used as a substrate (entries 1 and 2, 80%). However 
methyl substitution to vinyl group of enynes rather reduced the 




















position of vinyl group prevents the cyclopentene formation.[9b] 
When two phenyl groups were introduced to the terminal of vinyl 
(entry 8), the reaction time was shortened to 15 h. When only one 
phenyl group was added to the end of the vinyl, the reaction time 
was significantly shortened but there was on improvement in the 
yield of b (48%). It seems that this rearrangement is insensitive to 
the electronic effect of the aryl group (entries 8 and 9). An enyne 
bearing p-MeOC6H4 and tolyl group instead of a phenyl gave a 
reasonable yields (68% and 74%) at 120℃. The structure of 8b was 








 However, dienynes bearing no phenyl group at the terminal carbon 
of an alkene group gave only cyclopropanated products in high yields 
(10 and 11: [Eq. (4)]). Interestingly, phenyl group placed at the C-
3 position of vinylcyclopropanes rather than C-2 could not activate 
the thermal rearrangement. Thus the 2-aryl substituent on the 






















Space group P 21
a ( Å ) 10.0826 (10)
b ( Å ) 14.1675 (8)




Volume ( Å3 ) 1330.5 (2)
Z, d (calcd), Mg/cm3 2, 1.257
no. tot. collection 4840
no. unique data 4132
final R indices [ I>sigma (I) ] R1 = 0.0392, wR2 = 0.0891
R indeces (all data) R1 = 0.0500, wR2 = 0.0943  
 
 We next investigated a PtCl2-catalyzed reaction of O-tethered 
dienynes bearing a methyl group at the olefinic terminal carbon. We 
expected that this type of the substrate would be transformed to the 
2,4-dienal,[7] but when substrate 12 was reacted with 1.3 mol% of 
12 
 
PtCl2 in xylene at 140℃ for 24 h, a methylene-4-vinylcyclohex-






Thus, a subtle change in the substitution leads to a quite different 
reaction product. The product was derived from cycloisomerization 
followed by [1,5] hydrogen shift (retro-ene reaction).[11] For cis-
disubstituted vinylcyclopropanes, because the formation of retro-
ene product is kinetically favored over the ring expansion product[12], 
we observed only the former in this reaction. The scope of the 
reaction was further studied with a variety of dienynes having a 
methyl group at the olefin terminal carbon (Table 2). The reaction 
temperature was highly dependent upon the substrate. In the case of 
18, a reaction temperature of 80℃ was chosen. In some cases, a 
reaction temperature of 140℃ was required, in order to enhance the 
thermal reaction. When significant decomposition of the products 
was observed at 140℃, 100℃ was chosen as the reaction 
temperature. The yield found to be highly dependant upon the 
substituent at the alkene’s inner carbon and on the concentration of 
the catalyst. When a substrate 13 in entry 2 was reacted in the 
presence of 1.3 mol% PtCl2, no reaction was observed, but 57% of 
12 12c












the expected product 13c was isolated with a 33% recovery of 13. In 
the presence of 5.0 mol% of PtCl2 all of the reactants were 
decomposed, that is, no isolable compound was observed. 
Interestingly, for oxygen-tethered substrates (12 and 22), a higher 
yield was observed when 1.3 mol% PtCl2 was used instead of 5.0 
mol% PtCl2 (entries 1 and 11). Higher yields (> 80%) were 
observed with enynes having an aryl group at the alkene’s inner 
position (entries 6 and 7). This observation is consistent with the 
acceleration of 1,5-homodienyl hydrogen migrations due to 
electron-withdrawing aryl substituents.[13] Dienyne substrates 
(entries 2, 5 and 8) without in substituent an the alkene’s inner 
position gave the expected product in reasonable yields(57-65%).  
14 
 













  X R1 R2    
1 12[c]
 O Ph H 24 140 12c (65) 
2 13
 O H Me 48 140 13c (57)[e] 
3 14 NTs Ph H 24 140 14c (78) 
4 15 NTs p-
CH3OC6H4 
H 24 140 15c (69) 







  X R1 R2 R3    
6 17 NTs H H Ph 24 140 17c (83) 
7 18[d] NTs H Me Ph 48 80 18c (87) 
8 19 NTs H Me H 8 140 19c (65)[f] 
9 20 NTs Me Me Ph 24 100 20c (48) 
10 21 O H Ph Ph 24 140 21c (41) 





12 23[d] 20 140 23c (41)[g] 
 [a] Reaction conditions: 0.3mmol of substrate and 5 mol% PtCl2 were reacted in 6 mL 
xylene at presented temperature. [b] Isolated yield. [c] 1.3 mol% PtCl2 was used. 
[d] 10 mol% 
PtCl2 was used. 
[e] 33% of 13 was recovered. [f] Isolated as a mixture with 19a in 9% yield. 
[g] 9% of 23 was recovered. 
However, when a substrate bearing a methyl group at the alkene’s 
inner position (24 in [Eq. (6)] was reacted at 140℃ over a 4-day 
of a reaction period, compound 24a was isolated in 78% with a trace 



















Thus it seems that the electronic effect of the substituent at the 
alkene’s inner position has a profound effect on the yield of the 
reaction. When a dienyne 23 having an ethyl group instead of the 
methyl at the olefinic terminal carbon was used as a substrate (entry 
12), the expected reaction occurred, but the yield decreased to 
41 %. Oxygen-tethered dienynes with a methyl group at the olefinic 
terminal carbon (entries 1, 2, 10 and 11) gave the expected 
products at slightly lower yields (41-65%) than those of N-Ts-
tethered dienynes. It has been well documented[14a] that a [1,5] 
hydrogen shift pathway competes with a vinylcyclopropanes 
rearrangement when the 2-cis substituted groups at 
vinylcyclopropanes contain at least one hydrogen atom at the α-
position. However, our study shows that the 1,5-hydrogen shift is 
unique to dienyne substrates having a methyl group at the terminal 
carbon of the alkene moiety and is much preferred when dienynes 










2. Rhodium-Catalyzed rearrangement of Bicyclo[4.1.0]heptenes. 
 Bicyclo[4.1.0]heptenes derivatives were easily obtained from 
cyclopropylen-ynes by transition metal-catalyzed 
cycloisomerization reactions.[6g, 15] 1-
Cyclopropylbicyclo[4.1.0]hept-2-ene derivatives (25a - 40a) used 
in this study were easily obtained by PtCl2-catalyzed cyclo-






In hope of finding a new transformation of bis-cyclopropane 
compounds into other compounds, we treated 25 (X = NTs, R1 = H, 
R2 = Me) with a cationic rhodium catalyst Rh(PPh3)(CO)Cl/AgSbF6. 
However, intractable compounds were obtained. When 26 (X = NTs, 
R1 = H, R2 = Ph) was reacted with Rh(PPh3)(CO)Cl/AgSbF6 in 1,4-
dioxane at 100℃ for 24 h, we could confirm the formation of a new 





Encouraged by this observation, we screened reaction conditions 
including a rhodium species, a counteranion, a reaction solvent, a 




(X = N-Ts, O)
PtCl2
(7)










Table 3. Platinum-Catalyzed Rearrangement Reaction
[a]
Entry Substrate t (h) Product (%)[b]
R
1 26 C6H5 7 83
2 27 4-CH3C6H4 4 85
3 28 4-CH3OC6H4 4 84
4 29 4-ClC6H4 4 79
5 30 4-FC6H4 4 80
6 31 4-F3CC6H4 4 80
7 32 tert-butylbenzene 5 59
8 33 3-CH3C6H4 4 77
9 34 3-CH3OC6H4 3 80
10 35 3-ClC6H4 4 71
11 36 m-xylene 4 60
12 37 naphthyl 4 79>





















Table 4. Variety of Rhodium-Catalyzed Rearrangement Reaction of a
Entry Catalysts (mol%) Solvent Time (h) Temp (℃) Product (%)
[a]
1 Rh(CO)(PPh3)2Cl (10) / AgSbF6 (12) 1,4-dioxane 4 100 36
2 Rh(CO)(PPh3)2Cl (10) / AgSbF6 (12) 1,2-DCE 4 80 68
3 Rh(CO)(PPh3)2Cl (5) / AgSbF6 (9) 1,4-dioxane 24 100 trace
4 Rh(CO)(PPh3)2Cl (20) / AgSbF6 (24) 1,4-dioxane 1 100 54
5
[b]
Rh(CO)(PPh3)2Cl (10) / AgSbF6 (12) 1,2-DCE 4 80 24
6 Rh(CO)(PPh3)2Cl (10) / AgNO3 (12) 1,2-DCE 24 80 no reaction
7 Rh(CO)(PPh3)2Cl (10) / AgPF6 (12) 1,2-DCE 24 80 no reaction
8
[c]
Rh(CO)(PPh3)2Cl (10) / AgClO4 (12) 1,2-DCE 1 80 14
9
[d]
Rh(CO)(PPh3)2Cl (10) / AgOTf (12) 1,2-DCE 1 80 10
10 Rh(CO)(PPh3)2Cl (10) / AgBF4 (12) 1,2-DCE 4 80 74
11 RhCl(CO)(dppe) (10) / AgSbF6 (12) 1,4-dioxane 24 100 no reaction
12 [RhCl(COD)]2 (10) Toluene 17 100 trace
13 [RhCl(COD)]2 (10) / AgSbF6 Toluene 24 100 no reaction
14 [Rh(CO)2Cl]2 (5) / P(4-FC6H4)3 (20) / AgSbF6 (12) 1,2-DCE 24 80 no reaction
15 [PPN][Rh(CO)2Cl2] (4) / AgSbF6 (8) CH2Cl2 24 30 no reaction
16 [Rh(CO)2Cl]2
 
(5) THF 24 60 no reaction
17
[e] [RhCl(CO)(dppp)]2 (10) 1,2-DCE 24 80 no reaction
[a] Isolated yield. [b] Under CO(g) 1 atm. [c] 16% of reactant was remained. [d] 14% of reactant was remained. [e] CO 13 atm.  
 
 Yields of the reaction were highly sensitive to the reaction solvent. 
When 1,2-dichloroethane was used instead of 1,4-dioxane, the 
yield was dramatically increased to 36% (entry 2). As the amount of 
the catalyst used was increased, the yield was also increased 
(entries 3 and 4). The reaction conditions with an atmosphere of 
carbon monoxide were detrimental to the yield (entry 5). The yield 
of the reaction was highly dependent upon the counteranion (entries 
2 and 6-10). When the counteranion was NO3
- or PF6
- (entries 6 
and 7), no reaction was observed. Moreover, in case of ClO4
- and 
OTf- (entries 8 and 9), very poor yields (14 and 10% yields, 
respectively) were observed. The BF4
- anion (entry 10) was found 
to give the best yield (74%) in 1,2-dichloroethane. We also 
screened other neutral and cationic rhodium compounds, such as a 




[Rh(CO)2Cl]2 under carbon monoxide and [RhCl(CO)(dppp)]2 under 
13 atmosphere carbon monoxide. (Entries 12-17). Unfortunately, 
they are ineffective. Thus, we established that 
Rh(PPh3)2(CO)Cl/AgBF4 in 1,2-dichloroethane was the best catalyst 
system in respect to the yield. Formation of 26d was confirmed by 
1H NMR and 13C NMR spectroscopic investigations, high resolution 
mass spectrometry, and X-ray crystallographic structure (Figure 2). 
This was the first exposure of the skeleton of aryl-
hexahydroisoquinolines. 
 Using Rh(PPh3)2(CO)Cl/AgBF4 as a catalyst, we investigated the 
RhI-catalyzed transformation of various N-Ts tethered enynes to 
aryl-hexahydroisoquinolines (Table 5). All the reaction went to 
completion within 4 hours. Reasonable to high yields were observed 
for all enynes bearing an aryl with an electron-withdrawing (entries 
4-6 and 10) or –donating group (entries 2, 3, 7, 8 and 9). 
 
 







Space group P cab
a ( Å ) 13.4556 (11)
b ( Å ) 13.6408 (10)




Volume ( Å3 ) 3865.5
Z, d (calcd), Mg/cm3 8, 1.25
no. tot. collection 8093
no. unique data 4407
final R indices [ I>sigma (I) ] R1 = 0.156, wR2 = 0.125





Table 5. Rhodium-Catalyzed Rearrangement Reaction
[a]
Entry Substrate t (h) Product (%)[b]
R
1 26 C6H5 4 74
2 27 4-CH3C6H4 5 72
3 28 4-CH3OC6H4 4 70
4 29 4-ClC6H4 4 73
5 30 4-FC6H4 4 72
6 31 4-F3CC6H4 4 79
7 32 tert-butylbenzene 4 60
8 33 3-CH3C6H4 3 67
9 34 3-CH3OC6H4 4 62
10 35 3-ClC6H4 4 58
11 36 m-xylene 4 50
12 37 naphthyl - -







[a] Reaction conditions: substrate, 10 mol% [Rh(CO)(PPh3)2Cl] and 12 mol% AgBF4 were














It seems that the electronic nature of a substituent on the aryl ring 
does not exert any noticeable influence on the yield of the reaction. 
However, the position of the substituent (3- vs. 4- position: entry 
2 vs. 8, 3 vs. 9, and 4 vs. 10) has a slight influence on the yield of 
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the reaction. Substrates with a substituent at the 4-position produce 
10% higher yields than those of the 3-position. Interestingly, in the 
case of the tert-butyl group (entry 7), a rather low yield (60%) is 
obtained even the substituent is located at the 4-position. As 
expected, a substituent at the 2-position would exert a dramatic 
effect on the yield of the reaction. Thus, enynes having an aryl with 
ortho substituents did not give any products (entries 12 and 13). 
The reactant was recovered intact. Introduction of a methyl group to 
the –position of the N-Ts group did not have any effect on the 
yield of the reaction (entry 15). Unfortunately, all attempts with O-
tethered substrate 40a were unsuccessful. The substrate 40a 
readily decomposed in the presence of the catalytic system. Thus, 
no characterizable products were isolated. Thus, the transformation 
of the bis-cyclopropanyls to hexa-hydronaphthalenes is unique to 
the N-Ts tethered substrates. 
 Next we investigated the possibility of integrating the platinum- 
and rhodium-catalyzed reactions into a “one-pot” transformation. 
However, all attempts were not successful presumably due to the 
different reaction conditions of each catalyzed reaction. The first 
step was usually carried out in toluene and the second step in 1,2-
dichloroethane. When the second step was carried out in toluene, the 
yield of the second step was 36%. Thus, we had to find out a solvent 
which could be used in both steps. After much experimentation, 
1,2-dichloroethane was chosen as a solvent. However, the 
integration of the two reactions in 1,2- dichloroethane afforded the 
23 
 







A plausible reaction mechanism (Scheme 3) is proposed as follows. 
Although little mechanistic information has been obtained, a plausible 
mechanism is proposed on the basis of the above results and 
previous studies. The pre-coordination of the RhI center to the 
double bond (I) leads to the formation of a (-allyl)(-alkyl)RhIII 
intermediate (II). The intermediate III may be stabilized by the 
coordination of an aryl group.[16] A successive insertion leading to 
the metallacycle IV, followed by a reductive elimination allows the 
formation of the product. 
 








































 In conclusion, we have demonstrated the usefulness of a PtCl2-
catalyzed cycloisomerization and three different rearrangements 
leading to compounds which are difficult to prepare by conventional 
synthetic pathways: we have discovered synthetic pathway of 
bicyclo[4.1.0]hept-2-enes to 1-aryl-tetrahydro-1H-indendes, 
3-methylene-4-vinylcyclohex-1-enes, or aryl-
hexahydroisoquinolines. The reaction pathway are highly sensitive 
to the identity and position of substituents at the alkene moiety. 
However, each reaction pathway favours a special frame. Readily 
available enynes are used as starting materials for the reaction. 
Moreover, the experimental simplicity is noteworthy. Recently, 
transition-metal-catalyzed cyclopropanation has been widely 
developed. Thus, the methodology developed in this study could 
become a highly versatile tool for obtaining cycloaddition products 
that cannot be easily attained by other methods. Further research 





General remarks. All solvents were dried and distilled according to 
standard methods before use. [RhCl(CO)(PPh3)2] was prepared 
according to the literature procedures.[17] Platinum dichloride (PtCl2) 
was purchased from Strem Chemicals, Inc., and Silver 
tetrafluoroborate (AgBF4) was purchased from Acros Organics. 
Reactions were carried out in flame-dried glassware equipped with 
a stirring bar and sealed with a rubber septum under N2, unless 
otherwise indicated. Elevated temperatures were maintained in 
thermostat-controlled oil baths. Reactions were monitored by thin-
layer chromatography carried out on 0.25 mm E. Merck silica gel 
plates (60F-254) using UV light as a visualizing agent and acidic p-
anisaldehyde, and heat as a developing agent. Flash chromatography 
was carried out on Merck 60 silica gel (230 – 400 mesh). 1H and 13C 
NMR spectra were recorded with Bruker (300 MHz) spectrometer. 
1H NMR spectra were referenced to residual TMS (0 ppm) and 
reported as follows: chemical shift, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet). Chemical shifts of 
the 13C NMR spectra were measured relative to CDCl3 (75.00 ppm). 
Mass spectral data were obtained from the Korea Basic Science 
Institute (Daegu) on a Jeol JMS 700 high resolution mass 
spectrometer. Single crystal data for 8d, 22d were collected on an 
Enraf-Nonius CCD single crystal X-ray diffractometer at room 
temperature using graphite-monochromated Mo K α radiation (λ = 
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0.71073 Å). The structure was solved by direct methods using 
SHELXS-97 and refined by full-matrix least-squares with 
SHELXL-97. 
 
Preparation of 2-arylprop-2-en-1-ol 
HO R










Magnesium turnings (1.24 g, 51 mmol) were dissolved in THF (20 
mL) in a round-bottomed flask equipped with a stirrer. After aryl 
bromide (51 mmol) was added to the solution at 0℃, the resulting 
solution was stirred for 30 min. Then, copper iodide (0.16 g, 0.8 
mmol) was also added. After propargyl alcohol (1mL, 17 mmol) was 
dropwisely added to the solution at 0℃, then resulting solution was 
stirred at room temperature for 10 h. The reaction mixture was 
quenched with NH4Cl solution. The reaction product was extracted 
with ethyl acetate. The extract was dried over anhydrous MgSO4, 
and was evaporated to give a crude product. Flash chromatography 
on a silica gel eluting with hexane and ethyl acetate (v/v, 9:1) 
afforded 2-arylprop-2-en-1-ol. 
 











To a solution of N-(3-cyclopropylprop-2-ynyl)-4-
methylbenzenesulfonamide(0.872 g, 3.5 mmol) and PPh3 (0.92 g, 3.5 
mmol) in THF (30 mL) was added DIAD 
(DiisopropylAzodicarboxylate) (0.68 mL, 3.5 mmol) at room 
temperature. To the solution, 2-phenylprop-2-en-1-ol was added. 
The reaction mixture was stirred for 20 h at room temperature. 
After the solvent was removed by a rotary evaporator, the residue 
was purified by flash column chromatography eluting with 10% 
EtOAc in hexane. 
 
Representative procedure for platinum dichloride-catalyzed 
cycloisomerization and thermal rearrangement of dienynes. (b, c) 
PtCl2 and toluene (2 mL) were added to a tube-type Schlenk flask 
equipped with a stirring bar and capped with a rubber septum. Then 
a substrate and toluene (4 mL) were added to the flask. The 
resulting mixture was stirred until the substrate was completely 
disappeared (as checked by TLC) at corresponding temperature. 
The reaction product(s) was (were) purified by flash 
chromatography on a silica gel column eluting with n-hexane/ethyl 
acetate (v/v = 7/1 or 50/1). 
 
Representative procedure for Rh(I)-catalyzed cycloisomerization 
reaction of bicyclo[4.1.0]heptenes (d) 
[Rh(PPh3)(CO)Cl], AgBF4, and 1,2-dichloroethane (2 mL) were 
added to a Schlenk flask equipped with a stirring bar and capped 
with a rubber septum. The reaction mixture was stirred at room 
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temperature for 5 min. Then a substrate and 1,2-dichloroethane 
were added to the Schlenk flask. The resulting mixture was stirred 
until the substrate completely disappeared at 80℃. The reaction 
mixture was purified by flash chromatography on a silica gel column 
eluting with n-hexane/ethyl acetate (v/v = 20/1). 
 
Characterization of New compounds 
1: 1H NMR (300 MHz, CDCl3) δ 1.63 (ddd, J = 11.3, 7.2, 2,7 4 H), 
2.10-2.15 (m, 4 H), 4.25 (dd, J = 6.1, 1.1 Hz, 2 H), 4.33 (s, 2 H), 
6.16 (s, 1 H), 6.31 (dt, J = 15.9, 6.2 Hz, 1 H), 6.66 (d, J = 15.9 Hz, 
1 H), 7.23-7.42 (m, 5 H) ppm. 13C NMR (75 MHz, CDCl3) δ 21.4, 
22.2, 25.6, 29.1, 57.9, 70.0, 82.2, 88.3, 120.1, 125.5, 126.5, 127.7, 
128.5, 133.0, 135.4, 136.6 ppm.HRMS (EI) calc. for [C18H20O]: 
252.1514, found: 252.1511. 
2: 1H NMR (300 MHz, CDCl3) δ 1.54-1.61 (m, 4 H), 1.82 (br s, 2 
H), 2.02 (br s, 2 H), 2.42 (s, 3 H), 3.98 (d, J = 6.8 Hz, 2 H), 4.22 (s, 
2 H), 5.79 (s, 1 H), 6.12 (dt, J = 15.0, 7.5 Hz, 1 H), 6.57 (d, J = 
15.8 Hz, 1 H), 7.24-7.33 (m, 7 H), 7.76 (d, J = 7.9 Hz, 2 H) ppm. 
13C NMR (75 MHz, CDCl3) δ 21.3, 21.5, 22.1, 25.5, 28.9, 36.8, 48.6, 
78.8, 87.6, 119.7, 123.2, 126.5, 127.8, 127.9, 128.5, 129.4, 134.6, 
135.1, 136.0, 136.2, 143.3 ppm. HRMS (FAB) calc. for 
[C25H27NO2S]
+: 406.1841, found: 406.1837. 
3: 1H NMR (300 MHz, CDCl3) δ 1.57-1.64 (m, 4 H), 2.09-2.13 (m, 
7 H), 4.28 (s, 2 H), 4.31 (d, J = 3.0 Hz, 2 H), 5.94 (t, J = 6.7 Hz, 1 
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H), 6.14 (s, 1 H), 7.52-7.34 (m, 3 H), 7.41 (d, J = 7.1 Hz , 2 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 16.2, 21.4, 22.3, 25.6, 29.1, 58.0, 
66.3, 88.4, 88.2, 120.2, 123.6, 125.8, 127.3, 128.2, 135.4, 139.2, 
142.9 ppm. HRMS (EI) calc. for for [C19H22O]: 266.1671, found: 
266.1673. 
4: According to 1H NMR, the ratio of E:Z isomer was 5:1. (E-
isomer) 1H NMR (300 MHz, CDCl3) δ 1.46-1.48 (m, 4 H), 1.75 (br 
s, 2 H), 1.95 (br s, 2 H), 2.34 (s, 3 H), 3.73 (s, 3 H), 3.88 (d, J = 
6.8 Hz, 2 H), 4.14 (s, 2 H), 5.72 (s, 1 H), 5.89 (dt, J = 15.7, 6.9 Hz, 
1 H), 6.43 (d, J = 15.7 Hz, 1 H), 6.77 (d, J = 8.7 Hz, 2 H), 7.19 (d, 
J = 6.4 Hz, 2 H) , 7.22 (d, J = 5.8 Hz, 2 H), 7.69 (d, J = 8.2 Hz, 2 
H) ppm. (Z-isomer): 1H NMR (300 MHz, CDCl3) δ 1.47-1.55 (m, 6 
H), 1.95 (br s, 2 H), 2.40 (s, 3 H), 3.79 (s, 3 H), 4.11 (d, J = 6.6 Hz, 
2 H), 4.20 (s, 2 H), 5.49-5.58 (m, 2 H), 6.59 (d, J = 11.7 Hz, 1 H), 
6.84 (d, J = 8.0 Hz, 2 H), 7.16-7.20 (m, 4 H), 7.71 (d, J = 8.0 Hz, 
2 H) ppm. (E and Z-isomers): 13C NMR (75 MHz, CDCl3) δ 15.2, 
21.3, 21.5, 22.05, 22.12, 25.4, 25.5, 28.6, 28.9, 36.7, 37.0, 44.2, 
48.7, 55.1, 55.3, 65.8, 77.2, 78.6, 78.9, 87.5, 113.5, 113.9, 119.6, 
119.8, 120.8, 124.5, 127.1, 127.5, 127.7, 127.8, 128.6, 129.0, 129.4, 
129.6, 130.1, 133.2, 134.2, 134.8, 135.1, 135.9, 136.1, 143.2, 158.7, 
159.4 ppm. HRMS (EI) calc. for [C26H29NO3S]: 435.1868, found: 
435.1866. 
5: 1H NMR (300 MHz, CDCl3) δ 1.54-1.59 (m, 4 H), 1.83 (br s, 2 
H), 2.03 (br s, 2 H), 2.34 (s, 3 H), 2.43 (s, 3 H), 3.97 (d, J = 6.8 Hz, 
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2 H), 4.22 (s, 2 H), 5.79 (s, 1 H), 6.01-6.11 (m, 1 H), 6.54 (d, J = 
15.8 Hz, 1 H), 7.12 (d, J = 7.9 Hz, 2 H), 7.24 (d, J = 8.0 Hz, 2 H), 
7.30 (d, J = 8.1 Hz, 2 H), 7.77 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR 
(75 MHz, CDCl3) δ 21.2, 21.4, 21.5, 22.2, 25.5, 28.9, 36.8, 48.7, 
78.9, 87.6, 119.8, 122.1, 126.4, 127.9, 129.3, 129.5, 133.5, 134.6, 
135.2, 136.1, 137.9, 143.3 ppm. HRMS (EI) calc. for [C26H29NO2S]: 
419.1919, found: 419.1916. 
6: 1H NMR (300 MHz, CDCl3) δ 1.70 (s, 3 H), 2.45 (s, 3 H), 4.02 (d, 
J = 6.7 Hz, 2 H), 4.28 (s, 2 H), 5.03 (s, 1 H), 5.17 (s, 1 H), 6.16 (dt, 
J = 15.7, 6.8 Hz, 1 H), 6.62 (d, J = 15.8 Hz, 1 H), 7.29-7.40 (m, 7 
H), 7.81 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 21.5, 
23.1, 36.8, 48.8, 80.8, 87.0, 122.1, 123.1, 125.9, 126.6, 127.8, 
128.1, 128.6, 129.5, 134.8, 136.0, 136.2, 143.5 ppm. HRMS (FAB) 
calc. for [C22H23NO2S]
+: 366.1449, found: 366.1450. 
7: 1H NMR (300 MHz, CDCl3) δ 1.66 (s, 3 H), 1.75 (d, J = 6.9 Hz, 3 
H), 2.41 (s, 3 H), 3.99 (d, J = 6.7 Hz, 2 H), 4.27 (s, 2 H), 5.01 (s, 1 
H), 6.11 (dt, J = 15.7, 6.8 Hz, 1 H), 6.57 (d, J = 15.8 Hz, 1 H), 
7.27-7.32 (m, 7 H), 7.76 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 
MHz, CDCl3) δ 21.0, 21.5, 24.7, 37.0, 48.6, 83.6, 83.8, 104.4, 123.3, 
126.6, 127.8, 128.0, 128.6, 129.5, 134.7, 136.16, 136.21, 143.4, 
149.0  ppm. HRMS (EI) calc. for [C23H25NO2S]: 379.1606, found: 
379.1603. 
8: 1H NMR (300 MHz, CDCl3) δ 2.39 (s, 3 H), 3.72 (d, J = 6.7 Hz, 2 
H), 4.19 (d, J = 1.9 Hz, 2 H), 5.79 (s, 1 H), 5.93-6.03 (m, 1 H), 
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6.20 (d, J = 15.8 Hz, 1 H), 7.18-7.32 (m, 17 H), 7.73 (d, J = 8.2 
Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 21.5, 36.9, 48.4, 84.7, 
86.1, 21.5, 36.9, 48.4, 84.7, 86.1, 106.2, 122.8, 126.5, 127.7, 127.9, 
127.96, 128.01, 128.2, 128.3, 128.47, 128.54, 129.4, 129.7, 134.8, 
135.9, 136.1, 139.1, 140.8, 143.5, 152.9 ppm. HRMS (EI) calc. for 
[C33H29NO2S]: 503.1919, found: 503.1917. 
9: 1H NMR (300 MHz, CDCl3) δ 2.38 (s, 3 H), 4.01 (d, J = 6.7 Hz, 2 
H), 4.28 (s, 2 H), 5.88 (d, J = 16.3 Hz, 1 H), 6.12 (dt, J = 15.7, 6.8 
Hz, 1 H), 6.56 (d, J = 5.2 Hz, 1 H), 6.61 (d, J = 4.7 Hz, 1 H), 7.24-
7.36 (m, 12 H), 7.80 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 21.5, 37.1, 49.0, 84.1, 85.0, 107.1, 123.2, 126.2, 126.6, 
239.0, 128.1, 128.7, 128.8, 128.9, 129.6, 134.8, 135.9, 136.1, 136.2, 
141.8, 143.6 ppm. HRMS (EI) calc. for [C27H25NO2S]: 427.1606, 
found: 427.1608.  
10 : 1H NMR (300 MHz, CDCl3) δ 1.52-1.54 (m, 4 H), 1.79 (br s, 2 
H), 2.01 (br s, 2 H), 2.41 (s, 3 H), 3.81 (d, J = 6.3 Hz, 2 H), 4.19 (s, 
2 H), 5.23 (d, J = 10.2 Hz, 1 H), 5.29 (d, J = 17.2 Hz, 1 H), 5.69-
5.82 (m, 2 H), 7.29 (d, J = 8.3 Hz, 2 H), 7.74 (d, J = 7.9 Hz, 2 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 21.3, 21.5, 22.2, 25.5, 28.9, 36.7, 
49.0, 78.7, 87.5, 119.8, 127.8, 129.4, 129.6, 132.1, 135.1, 136.0, 
143.3 ppm. HRMS (EI) calc. for [C19H23NO2S]: 329.1450, found: 
329.1451. 
11: 1H NMR (300 MHz, CDCl3) δ 1.61 (s, 3 H), 1.78 (s, 3 H), 2.40 
(s, 3 H), 3.72 (s, 2 H), 4.15 (s, 2 H), 4.93 (s, 1 H), 4.97 (s, 2 H), 
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5.09 (s, 1 H), 7.29 (d, J = 8.1 Hz, 2 H), 7.74 (d, J = 8.1 Hz, 2 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 19.7, 21.5, 23.0, 36.2, 52.5, 80.6, 
86.9, 115.4, 121.9, 125.9, 127.8, 129.4, 136.0, 139.2, 143.3 ppm. 
HRMS (EI) calc. for [C17H21NO2S]: 303.1293, found: 303.1290.
 
12: 1H NMR (300 MHz, CDCl3) δ 1.57-1.64 (m, 4 H), 1.68 (d, J = 
6.9 Hz, 3 H), 2.09-2.11 (m, 4 H), 4.25 (s, 2 H), 4.28 (s, 2 H), 5.89 
(q, J = 6.9 Hz, 1 H), 6.11 (s, 1 H), 7.24-7.28 (m, 3 H), 7.32-7.37 
(m, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 14.7, 21.5, 22.3, 25.6, 
29.2, 57.5, 74.4, 82.3, 88.1, 120.2, 126.2, 126.9, 128.1, 128.7, 
135.2, 137.4, 138.7 ppm. HRMS (EI) calc. for [C19H22O]: 266.1671, 
found: 266.2671. 
13: 1H NMR (300 MHz, CDCl3) δ 1.53 (dd, J = 11.0, 5.6 Hz, 4 H), 
1.64 (s, 3 H), 1.68 (s, 3 H), 2.03 (dd, J = 6.2, 12.2 Hz, 4 H), 3.98 
(d, J = 7.0 Hz, 2 H), 4.16 (s, 2 H), 5.28 (t, J = 7.0 Hz, 1 H), 6.04 (s, 
1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 18.0, 21.5, 22.3, 25.6, 25.8, 
29.1, 57.6, 65.7, 82.6, 87.9, 120.2, 120.5, 135.1, 138.0 ppm. HRMS 
(EI) calc. for [C14H20O]: 204.1514, found: 204.1512. 
14: 1H NMR (300 MHz, CDCl3) δ 1.52-1.54 (m, 4 H), 1.66 (d, J = 
6.9 Hz, 3 H), 1.79 (br s, 2 H), 2.01 (br s, 2 H), 2.38 (s, 3 H), 4.09 
(s, 2 H), 4.12 (s, 2 H), 5.76 (s, 1 H), 5.85 (q, J = 6.8 Hz, 1 H), 
7.20-7.25 (m, 5 H), 7.31 (dd, J = 15.4, 7.9 Hz, 2 H), 7.65 (d, J = 
8.1 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 14.8, 21.4, 21.5, 22.2, 
25.5, 28.9, 36.4, 52.8, 78.9, 87.7, 119.9, 126.8, 127.2, 127.8, 128.2, 
128.8, 129.3, 134.9, 135.0, 136.1, 137.7, 143.1 ppm. HRMS (EI) 
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calc. for [C26H29NO2S]: 419.1919, found: 419.1918. 
15: 1H NMR (300 MHz, CDCl3) δ 1.53-1.55 (m, 4 H), 1.68 (d, J = 
6.9 Hz, 3 H), 1.79 (br s, 2 H), 2.02 (br s, 2 H), 2.40 (s, 3 H), 3.82 
(s, 3 H), 4.06 (s, 2 H), 4.10 (s, 2 H), 5.76 (s, 1 H), 5.80 (d, J = 7.0 
Hz, 1 H), 6.87 (d, J = 8.7 Hz, 2 H), 7.16 (d, J = 8.6 Hz, 2 H), 7.24 
(d, J = 8.1 Hz, 2 H), 7.66 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 
MHz, CDCl3) δ 14.9, 21.4, 21.5, 22.2, 25.5, 28.9, 36.3, 52.9, 55.2, 
79.0, 87.6, 113.6, 119.9, 126.4, 127.8, 129.3, 129.8, 129.9, 134.3, 
135.0, 136.2, 143.1, 158.6 ppm. HRMS (EI) calc. for [C26H29NO3S]: 
435.1868, found: 435.1866. 
16: 1H NMR (300 MHz, CDCl3) δ 1.52-1.53 (m, 4 H), 1.69 (d, J = 
6.1 Hz, 3 H), 1.79 (br s, 2 H), 2.01 (br s, 2 H), 2.41 (s, 3 H), 3.74 
(d, J = 6.7 Hz, 2 H), 4.17 (s, 2 H), 5.34-5.43 (m, 1 H), 5.64-5.74 
(m, 1 H), 5.76 (s, 1 H), 7.28 (d, J = 8.4 Hz, 2 H), 7.73 (d, J = 8.2 
Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 17.8, 21.4, 21.5, 22.2, 
25.5, 28.9, 36.4, 48.3, 79.0, 87.3, 119.9, 124.7, 127.82, 129.3, 
131.4, 135.0, 143.2 ppm. HRMS (EI) calc. for [C20H25NO2S]: 
343.1606, found: 343.1606. 
17: 1H NMR (300 MHz, CDCl3) δ 1.67 (d, J = 6.9 Hz, 3 H), 2.39 (s, 
3 H), 4.09 (s, 2 H), 4.12 (s, 2 H), 5.31 (dd, J = 17.1, 2.5 Hz, 1 H), 
5.36 (dd, J = 11.3, 2.5 Hz, 1 H), 5.51 (dd, J = 17.0, 11.3 Hz, 1 H), 
5.85 (q, J = 6.9 Hz, 1 H), 7.22 (dd, J = 15.2, 6.9 Hz, 5 H), 7.32 (dd, 
J = 14.6, 7.2 Hz, 2 H), 7.64 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 
MHz, CDCl3) δ 14.9, 21.5, 36.3, 53.0, 82.7, 84.3, 116.3, 127.0, 127.2, 
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127.8, 128.2, 128.7, 129.3, 134.9, 136.0, 137.6, 143.2 ppm. HRMS 
(EI) calc. for [C21H23NO2S]: 365.1449, found: 365.1449. 
18: 1H NMR (300 MHz, CDCl3) δ 1.64 (s, 2 H), 1.67 (d, J = 6.9 Hz, 
4 H), 2.37 (s, 3 H), 4.09 (s, 2 H), 4.13 (s, 2 H), 4.96 (s, 1 H), 5.10 
(m, 1 H), 5.85 (q, J = 6.9 Hz, 1 H), 7.20-7.25 (m, 5 H), 7.32 (dd, J 
= 15.3, 7.9 Hz, 2 H), 7.66 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 
MHz, CDCl3) δ 14.9, 21.5, 23.1, 36.3, 52.9, 81.0, 87.0, 122.0, 126.0, 
127.0, 127.2, 127.8, 128.2, 128.7, 129.4, 134.9, 136.0, 137.6, 143.3 
ppm. HRMS (EI) calc. for [C23H25NO2S]: 379.1606, found: 379.1605. 
19: 1H NMR (300 MHz, CDCl3) δ 1.69 (d, J = 6.4 Hz, 3 H), 2.40 (s, 
3 H), 3.73 (d, J = 6.8 Hz, 2 H), 4.17 (s, 2 H), 5.23-5.54 (m, 4 H), 
5.69 (dd, J = 15.1, 6.6 Hz, 1 H), 7.27 (d, J = 9.4 Hz, 2 H), 7.73 (d, J 
= 8.2 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 17.8, 21.5, 36.2, 
48.5, 82.6, 84.1, 116.3, 124.6, 127.2, 129.4, 131.6, 136.0, 143.3 
ppm. HRMS (FAB) calc. for [C16H19NO2S]
+: 290.1215, found: 
290.1211. 
20: 1H NMR (300 MHz, CDCl3) δ 1.41 (d, J = 9.4 Hz, 3 H), 1.49 (d, 
J = 6.9 Hz, 3 H), 1.55 (d, J = 6.7 Hz, 3 H), 2.25 (s, 3 H), 4.01 (d, J 
= 4.6 Hz, 4 H), 5.46 (d, J = 6.9 Hz, 1 H), 5.75 (q,  J = 6.6 Hz, 1 H), 
7.10-7.15 (m, 5 H), 7.19-7.23 (m, 2 H), 7.55 (d, J = 7.9 Hz, 2 H)  
ppm. 13C NMR (75 MHz, CDCl3) δ 14.0, 14.9, 16.5, 21.5, 36.4, 52.9, 
77.9, 89.0, 117.6, 126.9, 127.2, 127.8, 128.2, 128.8, 129.4, 132.8, 
135.0, 136.2, 137.7, 143.2 ppm. HRMS (EI) calc. for [C24H27NO2S]: 
393.1762, found: 393.1762. 
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21: 1H NMR (300 MHz, CDCl3) δ 1.69 (d, J = 6.8 Hz, 3 H), 4.35 (s, 
2 H), 4.37 (s, 2 H), 5.67 (s, 1 H), 5.93 (s, 2 H), 7.27 (d, J =6.2 Hz, 
2 H), 7.34 (d, J =7.3 Hz, 4 H), 7.63 (d, J = 7.3 Hz, 2 H) ppm. 13C 
NMR (75 MHz, CDCl3) δ 14.7, 57.5, 74.7, 85.4, 86.8, 121.1, 125.8, 
126.0, 126.6, 127.0, 128.2, 128.4, 128.7, 130.1, 137.0, 137.4, 138.6 
ppm. HRMS (EI) calc. for [C21H20O]: 288.1514, found: 288.1512. 
22: 1H NMR (300 MHz, CDCl3) δ 1.60 (d, J = 6.9 Hz, 3 H), 4.32 (s, 
4 H), 5.92 (q, J = 6.9 Hz, 1 H), 6.17 (dt, J = 16.2, 1.7 Hz, 1 H), 
6.95 (d, J = 16.3 Hz, 1 H ), 7.26-7.39 (m, 8 H) ppm. 13C NMR (75 
MHz, CDCl3) δ 14.7, 57.7, 74.7, 85.5, 87.6, 107.6, 126.27, 126.36, 
126.9, 128.2, 128.65, 128.69, 128.72, 128.70, 136.1, 137.4, 138.6, 
141.7 ppm. HRMS (EI) calc. for [C21H20O]: 288.1514, found: 
288.1512. 
23: 1H NMR (300 MHz, CDCl3) δ 0.94 (t, J = 7.5 Hz, 3 H), 1.53-
1.55 (m, 4 H), 1.80 (br s, 2 H), 2.01 (br s, 2 H), 2.01-2.11 (q, J = 
7.4 Hz, 2 H), 2.40 (s, 3 H), 4.08 (s, 2 H), 4.13 (s, 2 H), 5.74 (d, J = 
7.4 Hz, 1 H), 5.76-5.78 (m, 1 H), 7.19-7.25 (m, 5 H), 7.32 (d, J = 
13.6, 6.3 Hz, 2 H), 7.66 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 14.4, 21.4, 21.5, 22.2, 22.3, 25.5, 28.9, 36.3, 52.8, 79.0, 
87.6, 119.9, 127.2, 127.8, 128.2, 128.6, 129.3, 133.3, 134.4, 135.0, 
136.1, 138.0, 143.1 ppm. HRMS (EI) calc. for [C27H32NO2S]: 
433.2075, found: 433.2075. 
24: 1H NMR (300 MHz, CDCl3) δ 1.44-1.46 (m, 4 H), 1.55 (d, J = 
6.7 Hz, 3 H), 1.59 (s, 3 H), 1.68 (br s, 2 H), 1.93 (br s, 2 H), 2.33 
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(s, 3 H), 3.60 (s, 2 H), 4.01 (s, 2 H), 5.39 (q, J = 6.5 Hz, 1 H), 5.64 
(br s, 1 H), 7.20 (d, J = 8.1 Hz, 2 H), 7.66 (d, J = 8.2 Hz, 2 H) ppm. 
13C NMR (75 MHz, CDCl3) δ 13.5, 13.6, 21.4, 21.5, 22.2, 25.5, 28.9, 
36.0, 54.2, 78.9, 87.4, 120.0, 124.9, 127.8, 129.3, 129.8, 134.9, 
136.2, 143.1 ppm. HRMS (EI) calc. for [C21H27NO2S]: 357.1762, 
found: 357.1762. 
25: 1H NMR (300 MHz, CDCl3) δ 7.73 (d, J = 8.2 Hz, 2 H), 7.30 (d, 
J = 8.4 Hz, 2 H), 4.95 (s, 2 H), 3.982 (s, 1 H), 3.976 (s, 1 H), 3.70 
(s, 2 H), 2.44 (s, 3 H), 1.76 (s, 3 H), 0.85 – 0.96 (m, 1 H), 0.56 – 
0.63 (m, 2 H), 0.26 – 0.31 (m, 2 H) ppm. 13C NMR (75 MHz, CDCl3) 
δ 143.22, 139.40, 136.28, 129.30, 127.81, 115.20, 89.26, 67.52, 
52.31, 36.02, 21.52, 19.74, 7.82, -0.94 ppm. HRMS (EI) calc. for 
[C17H21O2SN]: 303.1293, found 303.1293. 
26: 1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 8.1 Hz, 2 H), 7.53 (d, 
J = 6.8 Hz, 2 H), 7.25 – 7.37 (m, 5 H), 5.56 (s, 1 H), 5.32 (s, 1 H), 
4.22 (s, 2 H), 3.93 (s, 2 H), 2.45 (s, 3 H), 0.89 – 0.95 (m, 1 H), 
0.57 – 0.63 (m, 2 H), 0.25 – 0.30 (m, 2 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 143.39, 141.45, 137.84, 135.82, 129.36, 128.44, 128.12, 
127.99, 126.43, 116.99, 89.73, 67.36, 49.93, 36.10, 21.55, 7.86, -
0.82 ppm. HRMS (EI) calc. for [C22H23NO2S]: 365.1450, found: 
365.1447. 
27: 1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 7.9 Hz, 2 H), 7.43 (d, 
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J = 7.8 Hz, 2 H), 7.31 (d, J = 7.8 Hz, 2 H), 7.15 (d, J = 7.6 Hz, 2 H), 
5.52 (s, 1 H), 5.26 (s, 1 H), 4.20 (s, 2 H), 3.92 (s, 2 H), 2.45 (s, 3 
H), 2.35 (s, 3 H), 0.93 (br s, 1 H), 0.60 (d, J = 6.1 Hz, 2 H), 0.27 (d, 
J = 2.3 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.30, 141.22, 
137.95, 135.85, 134.87, 129.31, 129.11, 128.00, 126.29, 116.14, 
89.62, 67.39, 49.95, 36.03, 21.53, 21.15, 7.83, -0.95 ppm. HRMS 
(EI) calc. for [C23H25NO2S]: 379.1606, found: 379.1610. 
28: 1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 8.3 Hz, 2 H), 7.50 (d, 
J = 8.8 Hz, 2 H), 7.32 (d, J = 8.1 Hz, 2 H), 6.88 (d, J = 8.8 Hz, 2 H), 
5.48 (s, 1 H), 5.21 (s, 1 H), 4.19 (s, 2 H), 3.91 (d, J = 1.8Hz, 2 H), 
3.81 (s, 3 H), 2.45 (s, 3 H), 0.88 - 0.97 (m, 1 H), 0.56 - 0.63 (m, 
2 H), 0.24 - 0.29 (m, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 
159.53, 143.32, 140.58, 135.76, 130.07, 129.30, 128.00, 127.59, 
115.35, 113.76, 89.62, 67.31, 55.26, 50.03, 35.95, 21.51, 7.81, -
0.97 ppm. HRMS (EI) calc. for [C23H25NO2S]: 395.1555, found: 
395.1555. 
29: 1H NMR (300 MHz, CDCl3) δ 7.73 (d, J = 8.2 Hz, 2 H), 7.48 (d, 
J = 8.6 Hz, 2 H), 7.30 – 7.33 (m, 4 H), 5.55 (s, 1 H), 5.33 (s, 1 H), 
4.19 (s, 2 H), 3.90 (d, J = 1.7Hz, 2 H), 2.46 (s, 3 H), 0.93 (dd, J = 
4.0, 9.1 Hz, 1 H), 0.57 – 0.64 (m, 2 H), 0.24 – 0.29 (m, 2 H) ppm. 
13C NMR (75 MHz, CDCl3) δ 143.51, 140.42, 136.10, 135.64, 134.01, 
129.39, 128.61, 127.97, 127.78, 117.61, 89.84, 67.13, 49.90, 36.05, 
21.56, 7.87, -0.96 ppm. HRMS (EI) calc. for [C22H22NO2ClS]: 
399.1060, found: 399.1060. 
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30: 1H NMR (300 MHz, CDCl3) δ 7.75 (d, J = 8.2 Hz, 2 H), 7.54 (m, 
2 H), 7.33 (d, J = 8.1 Hz, 2 H), 7.04 (t, J = 8.7 Hz, 2 H), 5.53 (s, 1 
H), 5.31 (s, 1 H), 4.21 (s, 2 H), 3.92 (d, J = 1.5 Hz, 2 H), 2.46 (s, 3 
H), 0.90 – 0.96 (m, 1 H), 0.58 - 0.65 (m, 2 H), 0.25 – 0.31 (m, 1H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 143.50, 140.37, 135.63, 129.38, 
128.22, 128.11, 127.95, 117.04, 115.43, 115.14, 89.84, 67.11, 
50.04, 36.03, 21.54, 7.86, -0.96 ppm. HRMS (EI) calc. for 
[C22H22FNO2S]: 383.1355, found: 383.1359. 
31: 1H NMR (300 MHz, CDCl3) δ 7.73 (d, J = 8.2 Hz, 2 H), 7.67 (d, 
J = 8.3 Hz, 2 H), 7.59 (d, J = 8.4 Hz, 2 H), 7.32 (d, J = 8.1 Hz, 2 H), 
5.65 (s, 1 H), 5.44 (s, 1 H), 4.25 (s, 2 H), 3.91 (d, J = 1.3 Hz, 2 H), 
2.44 (s, 3 H), 0.91 – 0.95 (m, 1 H), 0.68 – 0.64 (m, 2 H), 0.25 – 
0.29 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.66, 140.45, 
135.53, 129.43, 127.92, 126.81, 125.42, 125.36, 125.31, 119.26, 
90.07, 66.91, 49.86, 36.10, 21.46, 7.85, -1.00 ppm. HRMS (EI) calc. 
for [C23H22F3NO2S]: 433.1323, found: 433.1325. 
32: 1H NMR (300 MHz, CDCl3) δ 7.67 (d, J = 8.2 Hz, 2 H), 7.42 (d, 
J = 8.4 Hz, 2 H), 7.23 – 7.31 (m, 4 H), 5.48 (s, 1 H), 5.20 (s, 1 H), 
4.14 (s, 2 H), 3.86 (d, J = 1.5Hz, 2 H), 2.38 (s, 3 H), 1.25 (s, 9 H), 
0.82 – 0.86 (m, 1 H), 0.51 – 0.54 (m, 2 H), 0.19 – 0.22 (m, 2 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 151.12, 143.34, 141.02, 135.84, 
134.82, 129.33, 128.02, 126.06, 125.37, 116.30, 89.67, 67.42, 
49.94, 36.08, 34.56, 31.29 , 21.55, 7.85, -0.93 ppm. HRMS (EI) 
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calc. for [C26H31NO2S]: 421.2076, found: 421.2074. 
33: 1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 8.2 Hz, 2 H), 7.32 (br 
s, 2 H), 7.10 – 7.32 (m, 4 H), 5.53 (s, 1 H), 5.30 (s, 1 H), 4.20 (s, 2 
H), 3.94 (d, J = 1.6Hz, 2 H), 2.45 (s, 3 H), 2.36 (s, 3 H), 0.90 – 
1.01 (m, 1 H), 0.57 – 0.64 (m, 2 H), 0.26 – 0.31 (m, 2 H) ppm. 13C 
NMR (75 MHz, CDCl3) δ 143.29, 141.58, 137.91, 135.91, 129.49, 
129.31, 128.84, 128.29, 127.95, 127.16, 123.52, 116.66, 89.63, 
67.45, 49.90, 36.10, 21.51, 21.47, 7.82, -0.95 ppm. HRMS (EI) calc. 
for [C23H25NO2S]: 379.1606, found: 379.1606. 
34: 1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 8.1 Hz, 2 H), 7.23 – 
7.33 (m, 4 H), 7.12 (d, J = 6.4Hz, 1 H), 6.86 (d, J = 7.1 Hz, 1 H), 
5.58 (s, 1 H), 5.32 (s, 1 H), 4.21 (s, 2 H), 3.94 (s, 2 H), 3.84 (s, 3 
H), 2.45 (s, 3 H), 0.91 – 0.94 (m, 1 H), 0.57 – 0.63 (m, 2 H), 0.25 – 
0.30 (m, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 159.63, 143.37, 
141.28, 139.25, 135.85, 129.35(Ts carbon + 3-MeO carbon), 
127.96, 118.78, 117.15, 114.08, 111.86, 89.74, 67.34, 55.36, 49.97, 
36.11, 21.54, 7.86, -0.93 ppm. HRMS (EI) calc. for [C23H25NO3S]: 
395.1555, found: 395.1552. 
35: 1H NMR (300 MHz, CDCl3) δ 7.73 (d, J = 8.2Hz, 2 H), 7.42 – 
7.45 (m, 1 H), 7.27 – 7.33 (m, 5 H),  5.56 (s, 1 H), 5.37 (s, 1 H), 
4.19 (s, 2 H), 3.93 (d, J = 1.6 Hz, 2 H), 2.45 (s, 3 H), 0.87 – 0.99 
(m, 1 H), 0.61 (dt,  J = 4.1, 6.7 Hz, 2 H), 0.26 – 0.32 (m, 2 H) ppm. 
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13C NMR (75 MHz, CDCl3) δ 143.50, 140.51, 139.80, 135.72, 134.32, 
129.74, 129.40, 128.13, 127.96, 126.57, 124.781, 118.09, 89.90, 
67.24, 49.79, 36.19. 21.56, 7.89, -0.93 ppm. HRMS (EI) calc. for 
[C22H22NO2SCl]: 399.1060, found: 399.1060. 
36: 1H NMR (300 MHz, CDCl3) δ 7.74 (d, J = 8.2 Hz, 2 H), 7.30 (d, 
J = 8.0 Hz, 2 H), 7.12 (s, 2 H), 6.94 (s, 1 H), 5.51 (s, 1 H), 5.28 (s, 
1 H), 4.19 (s, 2 H), 3.94 (s, 2 H), 2.44 (s, 3 H), 2.32 (s, 6 H), 0.91 
– 0.99 (m, 1 H), 0.57 – 0.64 (m, 2 H), 0.27 – 0.32 (m, 2 H) ppm. 13C 
NMR (75 MHz, CDCl3) δ 143.29, 141.74, 138.01, 137.83, 136.01, 
129.76, 129.33, 127.97, 124.33, 116.43, 89.63, 67.58, 49.94, 36.16, 
21.55, 21.37, 7.87, -0.90 ppm. HRMS (EI) calc. for [C24H27NO2S]: 
393.1763, found: 393.1759.37: 1H NMR (300 MHz, CDCl3) δ 8.00 – 
8.03 (m, 1 H), 7.83 – 7.86 (m, 1 H), 7.78 (d, J = 8.1 Hz, 1 H), 7.63 
(d, J = 8.2Hz, 2 H), 7.45 – 7.48 (m, 2 H), 7.41 (d, J = 8.0Hz, 1 H), 
7.31 (d, J = 6.9Hz, 1 H), 7.18 (d, J = 8.1Hz, 2 H), 5.74 (s, 1 H), 
5.35 (s, 1 H), 4.18 – 4.20 (m, 4 H), 2.37 (s, 3 H), 0.92 – 1.00 (m, 1 
H), 0.59 (dt, J = 4.1, 6.6 Hz, 2 H), 0.27 – 0.32 (m, 2 H) ppm. 13C 
NMR (75 MHz, CDCl3) δ 143.22, 142.13, 137.95, 136.23, 133.71, 
131.28, 129.29, 128.40, 127.93, 127.66, 126.18, 125.81, 125.24, 
117.89, 89.75, 67.83, 51.63, 36.92, 21.49, 7.88, -0.88 ppm. HRMS 
(EI) calc. for [C26H25NO2S]: 415.1606, found: 415.1608. 
38: 1H NMR (300 MHz, CDCl3) δ 7.70 (d, J = 8.2 Hz, 2 H), 7.25 (d, 
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J = 8.0 Hz, 2 H), 6.87 (s, 2 H), 5.58 (s, 1 H), 5.02 (s, 1 H), 4.21 (s, 
2 H), 3.84 (s, 2 H), 2.40 (s, 3 H), 2.27 (s, 3 H), 2.23 (s, 6 H), 0.87 
(dd, J = 4.7, 11.6 Hz, 1 H), 0.54 – 0.60 (m, 2 H), 0.23 – 0.28 (m, 2 
H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.26, 142.24, 136.89, 
136.42, 135.80, 129.32, 128.23, 127.69, 114.14, 89.63, 67.99, 
49.96, 37.23, 31.61, 22.67, 21.49, 20.97, 19.53, 14.14, 7.81, -0.96 
ppm. HRMS (EI) calc. for [C25H29NO2S]: 407.1919, found: 407.1915. 
39: 1H NMR (300 MHz, CDCl3) δ 7.72 (d, J = 8.2 Hz, 2 H), 7.47 (m, 
2 H), 7.25 – 7.37 (m, 5 H), 5.49 (d, J = 5.0 Hz, 2 H), 4.81 (q, J = 
6.9 Hz, 1 H), 4.39 (d, J = 16.8Hz, 1 H), 3.98 (d, J = 16.8 Hz, 1 H), 
2.43 (s, 3 H), 1.28 (d, J = 7.1Hz, 3 H), 0.93 – 1.02 (m, 1 H), 0.61 
(dd, J = 2.3, 8.3 Hz, 2 H), 0.25 – 0.30 (m, 2 H) ppm. 13C NMR (75 
MHz, CDCl3) δ 144.78, 143.28, 139.26, 135.97, 129.35, 128.36, 
127.85, 126.46, 115.28, 89.03, 72.17, 48.40, 47.15, 22.83, 21.52, 
7.97, 7.89, -0.94 ppm. HRMS (EI) calc. for [C23H25NO2S]: 379.1606, 
found: 397.1609. 
40: 1H NMR (300 MHz, CDCl3) δ 7.49 (d, J = 7.6 Hz, 2 H), 7.28 – 
7.36 (m, 3 H), 5.53 (s, 1 H), 5.36 (s, 1 H), 4.44 (s, 2 H), 4.14 (s, 2 
H), 1.24 – 1.30 (m, 1 H), 0.75 – 0.83 (m, 2 H), 0.67 – 0.73 (m, 2 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 143.61, 138.62, 128.35, 127.78, 
126.06, 115.03, 90.35, 86.48, 71.15, 57.61, 8.22, -0.51 ppm. HRMS 
(EI) calc. for [C15H16O]: 212.1201, found 212.1200. 
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10a: 1H NMR (300 MHz, CDCl3) δ 0.50-0.53 (m, 1 H), 0.96 (dd, J = 
8.7, 4.4 Hz, 1 H), 1.47-1.50 (m, 5 H), 1.87 (br s, 2 H), 1.94 (br s, 2 
H), 2.42 (s, 3 H), 3.04 (dd, J = 11.6, 2.5 Hz, 1 H), 3.91 (d, J = 11.6 
Hz, 1 H), 5.30 (d, J = 8.2 Hz, 1 H), 5.45 (s, 1 H), 6.36 (d, J = 8.2 
Hz, 2 H), 7.31 (d, J = 8.1 Hz, 2 H), 7.65 (d, J = 8.2 Hz, 2 H) ppm. 
13C NMR (75 MHz, CDCl3) δ 19.1, 21.5, 22.3, 22.9, 23.2, 25.0, 25.1, 
26.5, 41.0, 114.6, 120.7, 122.1, 127.0, 129.7, 134.9, 138.4, 143.6 
ppm. HRMS (EI) calc. for [C19H23NO2S]: 329.1450, found: 329.1488. 
11a: 1H NMR (300 MHz, CDCl3) δ 0.66 (d, J = 4.6 Hz, 1 H), 0.78 (d, 
J = 4.6 Hz, 1 H), 0.95 (s, 3 H), 1.59 (s, 3 H), 2.35 (s, 3 H), 2.65 (d, 
J = 11.6 Hz, 1 H), 3.78 (d, J = 11.6 Hz, 1 H), 4.63 (s, 1 H), 4.81 (s, 
1 H), 5.12 (d, J = 8.0 Hz, 1 H), 6.29 (d, J = 8.0 Hz, 1 H), 7.24 (d, J 
= 8.0 Hz, 2 H), 7.59 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 17.2, 21.6, 22.4, 23.3, 29.7, 30.9, 46.5, 113.2, 115.8, 121.0, 
127.0, 129.8, 135.1, 143.7, 144.5 ppm. HRMS (EI) calc. for 
[C17H21NO2S]: 303.1293, found: 303.1291. 
14a: 1H NMR (300 MHz, CDCl3) δ 0.86 (s, 4 H), 0.94 (s, 3 H), 
1.45-1.46 (m, 5 H), 1.73-1.77 (m, 2 H), 1.89 (br s, 2 H), 2.35 (s, 
3 H), 2.57 (d, J = 11.3 Hz, 1 H), 3.71 (d, J = 11.3 Hz, 1 H), 5.10 (d, 
J = 8.0 Hz, 1 H), 5.38 (s, 1 H), 6.18 (d, J = 8.0 Hz, 1 H), 7.23 (d, J 
= 8.0 Hz, 2 H), 7.57 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 11.0 14.2, 21.6, 22.3, 23.1, 25.3, 27.3, 27.8, 30.7, 32.3, 
47.2, 119.2, 120.0, 126.9, 127.0, 129.7, 134.9, 135.1, 143.6 ppm. 
HRMS (EI) calc. for [C21H27NO2S]: 357.1762, found: 357.1761. 
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25a: 1H NMR (300 MHz, CDCl3) δ 7.50 (d, J = 8.2 Hz, 2 H), 7.16 (d, 
J = 8.1 Hz, 2 H), 6.12 (d, J = 8.0 Hz, 1 H), 5.15 (d, J = 8.0 Hz, 1 H), 
3.64 (d, J = 11.3 Hz, 1 H), 2.55 (d, J = 11.3 Hz, 1 H), 2.27 (s, 3 H), 
1.02 (s, 3 H), 0.65 – 0.74 (m, 1 H), 0.35 – 0.41 (m, 1 H), 0.31 (d, J 
= 4.6 Hz, 1 H), 0.22 – 0.28 (m, 1 H), 0.16 (d, J = 4.4 Hz, 1 H), 0.01 
(dd, J = 1.4, 4.7 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.59, 
134.98, 129.74, 127.03, 120.12, 117.06, 46.67, 30.30, 23.58, 22.06, 
21.55, 17.31, 12.40, 5.00, 2.83 ppm. HRMS (EI) calc. for 
[C17H21O2SN]: 303.1293, found 303.1293. 
26a: 1H NMR (300 MHz, CDCl3) δ 7.63 – 7.66 (m, 2 H), 7.31 (d, J = 
8.0 Hz, 2 H), 7.25 – 7.29 (m, 5 H), 6.40 (dd, J = 1.0, 8.1 Hz, 1 H), 
5.34 (d, J = 8.1 Hz, 1 H), 3.96 (dd, J = 1.0, 11.5 Hz, 1 H), 2.99 (d, J 
= 11.5 Hz, 1 H), 2.43 (s, 3 H), 1.00 (d, J = 4.9 Hz, 1 H), 0.94 (d, J 
= 4.9 Hz, 1 H), 0.50 (m, 1 H), 0.33 – 0.42 (m, 1 H), 0.09 – 0.18 (m, 
1 H), -0.14 - -0.05 (m, 1 H), -0.20 (m, 1 H) ppm. 13C NMR (75 
MHz, CDCl3) δ 143.72, 139.21, 134.94, 129.91, 129.82, 128.34, 
127.09, 127.02, 121.23, 115.68, 48.09, 24.13, 21.58, 20.48, 13.82, 
2.84 ppm. HRMS (EI) calc. for [C22H23NO2S]: 365.1450, found: 
365.1448. 
27a: 1H NMR (300 MHz, CDCl3) δ 7.63 (d, J = 8.2 Hz, 2 H), 7.30 (d, 
J = 8.1 Hz, 2 H), 7.16 (d, J = 8.0 Hz, 2 H), 7.09 (d, J = 8.0 Hz, 2 H), 
6.38 (d, J = 8.1 Hz, 1 H), 5.31 (d, J = 8.1 Hz, 1 H), 3.94 (d, J = 
11.3 Hz, 1 H), 2.95 (d, J = 11.5 Hz, 1 H), 2.43 (s, 3 H), 2.32 (s, 3 
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H), 1.00 (d, J = 4.8 Hz, 1 H), 0.92 (d, J = 4.8 Hz, 1 H), 0.49 (qd, J 
= 5.2, 8.2 Hz, 1 H), 0.33 – 0.42 (m, 1 H), 0.13 (m, 1 H), -0.07 (m, 
1 H), -0.17 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.69, 
136.66, 136.17, 134.92, 129.80, 129.76, 129.04, 127.09, 121.15, 
115.60, 48.12, 39.71, 24.08, 21.08, 21.14, 20.60, 13.83, 2.88, 2.82 
ppm. HRMS (EI) calc. for [C23H25NO2S]: 379.1606, found: 379.1605. 
28a: 1H NMR (300 MHz, CDCl3) δ 7.59 – 7.62 (m, 2 H), 7.27 (d, J = 
8.0 Hz, 2 H), 7.13 – 7.17 (m, 2 H), 6.76 – 6.81 (m, 2 H), 6.34 (dd, J 
= 1.0, 8.1 Hz, 1 H), 5.28 (d, J = 8.1 Hz, 1 H), 3.91 (dd, J = 1.0, 
11.5 Hz, 1 H), 3.75 (s, 3 H), 2.90 (d, J = 11.3 Hz, 1 H), 2.40 (s, 3 
H), 0.95 (d, J = 4.9 Hz, 1 H), 0.86 (d, J = 5.2 Hz, 1 H), 0.46 (tt, J = 
5.2, 8.2 Hz, 1 H), 0.30 – 0.39 (m, 1H), 0.08 (m, 1 H), -0.12 - -
0.06 (m, 1 H), -0.26 - -0.17 (m, 1 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 158.51, 143.68, 134.93, 131.31, 130.93, 129.80, 127.08, 
121.09, 115.64, 113.69, 55.22, 48.11, 39.35, 24.14, 20.68, 13.78, 
2.83, 0.00 ppm. HRMS (EI) calc. for [C23H25NO3S]: 395.1555, found: 
395.1558. 
29a: 1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz, 2 H), 7.32 (d, 
J = 8.1 Hz, 2 H), 7.19 – 7.27 (m, 4 H), 6.39 (d,  J = 8.1 Hz, 1 H), 
5.33 (d, J = 8.1 Hz, 1 H), 3.93 (d, J = 11.5 Hz, 1 H), 2.93 (d, J = 
11.5 Hz, 1 H) , 2.44 (s, 3 H), 1.01 (d, J = 5.0 Hz, 1 H), 0.90 (d, J = 
4.9 Hz, 1 H), 0.44 – 0.53 (m, 1 H), 0.40 (m, 1 H), 0.13 (m, 1 H), -
0.11 - -0.03 (m, 1H) -0.21 (m, 1 H) ppm. 13C NMR (75 MHz, 
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CDCl3) δ 143.84, 137.76, 134.79, 131.26, 129.87, 128.59, 127.07, 
121.38, 115.47, 47.91, 39.29, 24.23, 21.60, 20.41, 13.74, 2.97, 2.91 
ppm. HRMS (EI) calc. for [C22H22NO2SCl]: 399.1060, found: 
399.1060. 
30a: 1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz, 2 H), 7.32 (d, 
J = 8.1 Hz, 2 H), 7.23 (dd, J = 6.1, 9.3 Hz, 2 H), 6.97 (t, J = 8.7 Hz, 
2 H), 6.39 (d, J = 8.2 Hz, 1 H), 5.33 (d, J = 8.1 Hz, 1 H), 3.94 (d, J 
= 11.4 Hz, 1 H), 2.94 (d, J = 11.5 Hz, 1 H), 2.43 (s, 3 H), 0.99 (d, J 
= 4.9 Hz, 1 H), 0.89 (d, J = 5.3 Hz, 1 H),  0.49 (td, J = 4.1, 3.4 Hz, 
1 H), 0.35 – 0.44 (m, 1 H), 0.13 (m, 1 H), -0.07 (m, 1 H), -0.22 
(m, 1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.78, 134.89, 131.50, 
131.39, 129.85, 127.06, 121.30, 115.56, 115.40, 48.05, 39.24, 
24.20, 21.58, 20.55, 13.74, 2.88 ppm. HRMS (EI) calc. for 
[C22H22NO2FS]: 383.1355, found: 383.1358. 
31a: 1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz, 2 H), 7.55 (d, 
J = 8.1 Hz, 2 H), 7.39 (d, J = 8.1 Hz, 2 H),  7.32 (d, J = 8.1 Hz, 2 
H), 6.42 (d, J = 8.1 Hz, 1 H), 5.35 (d, J = 8.1 Hz, 1 H), 3.94 (d, J = 
11.5 Hz, 1 H), 2.98 (d, J = 11.5 Hz, 1 H), 2.44 (s, 3 H), 1.07 (d, J = 
5.1 Hz, 1 H), 0.96 (d, J = 5.0 Hz, 1 H), 0.36 – 0.51 (m, 2 H), 0.15 
(m, 1 H), -0.08 (m, 1 H), -0.22 (m, 1 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 143.90, 143.32, 134.80, 130.27, 129.89, 127.08, 125.40, 
125.35, 121.63, 115.26, 47.87, 39.56, 24.33, 21.59, 20.40, 13.77, 




32a: 1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 7.6 Hz, 2 H), 7.27 – 
7.32 (m, 4 H), 7.18 (d, J = 7.5 Hz, 2 H), 6.38 (d, J = 7.9 Hz, 1 H), 
5.30 (d, J = 8.0 Hz, 1 H), 3.96 (d, J = 11.4 Hz, 1 H), 2.97 (d, J = 
11.4 Hz, 1 H), 2.43 (s, 3 H), 1.30 (s, 9 H), 1.00 (br s, 1 H), 0.95 (br 
s, 1 H), 0.42 (m, 2 H), 0.14 (d, J = 4.1 Hz, 1 H), -0.16 - -0.07 (m, 
2H) ppm. 13C NMR (75 MHz, CDCl3) δ 149.88, 143.66, 136.01, 
134.98, 129.79, 129.48, 127.09, 125.15, 121.15, 115.47, 48.04, 
39.69, 34.47, 31.35, 24.03, 21.58, 20.74, 13.83, 2.78 ppm. HRMS 
(EI) calc. for [C26H31NO2S]: 421.2076, found: 421.2074. 
33a: 1H NMR (300 MHz, CDCl3) δ 7.80 (d, J = 8.2 Hz, 2 H), 7.46 (d, 
J = 8.0 Hz, 2 H), 7.25 – 7.35 (m, 2 H), 7.21 (t, J = 7.9 Hz, 2 H), 
6.55 (d, J = 8.1 Hz , 1 H), 5.48 (d, J = 8.1 Hz, 1 H), 4.12 (d, J = 
11.5 Hz, 1 H), 3.14 (d, J = 11.5 Hz, 1 H), 2.58 (s, 3 H), 2.47 (s, 3 
H) 1.15 (d, J = 4.8 Hz , 1 H), 1.09 (d, J = 4.7 Hz, 1 H), 0.61 – 0.70 
(m, 1 H), 0.49 – 0.58 (m, 1 H), 0.29 (m, 1 H) 0.06 – 0.14 (m, 1 H), 
-0.03 - 0.04 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.75, 
139.13, 137.93, 134.99, 130.63, 129.85, 128.23, 127.81, 127.10, 
126.96, 121.22, 115.64, 48.17, 40.09, 24.11, 21.60, 21.43, 20.66, 
13.89, 2.87 ppm. HRMS (EI) calc. for [C23H25NO2S]: 379.1606, 
found: 379.1606. 
34a: 1H NMR (300 MHz, CDCl3) δ 7.78 (d, J = 8.1 Hz, 2 H), 7.45 (d, 
J = 8.1 Hz, 2 H), 7.34 (t, J = 7.9Hz, 1 H), 7.00 (d, J = 7.6 Hz, 1 H), 
6.92 (dd, J = 3.6, 11.8 Hz, 2 H), 6.54 (d, J = 8.1 Hz, 1 H), 5.46 (d, J 
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= 8.1 Hz, 1 H), 4.10 (d, J = 11.5 Hz, 1 H), 3.91 (s, 3 H), 3.13 (d, J 
= 11.5 Hz, 1 H), 2.56 (s, 3 H), 1.14 (d, J = 4.8 Hz, 1 H), 1.08 (d, J 
= 4.8 Hz, 1 H), 0.61 – 0.70 (m, 1 H), 0.48 – 0.57 (m, 1 H), 0.27 (m, 
1 H), 0.07 – 0.12 (m, 1 H), -0.03 - 0.04 (m, 1 H) ppm. 13C NMR 
(75 MHz, CDCl3) δ 159.52, 143.77, 140.76, 134.92, 129.85, 129.35, 
127.07, 122.29, 121.29, 115.79, 115.57, 112.24, 55.24, 48.03, 
40.10, 24.25, 21.59, 20.68, 13.84, 2.86 ppm.. HRMS (EI) calc. for 
[C23H25NO3S]: 395.1555, found: 395.1558. 
35a: 1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz, 2 H), 7.23 – 
7.34(m, 4 H), 7.16 – 7.25 (m, 2 H), 6.40 (d, J = 8.1 Hz, 1 H), 5.34 
(d, J = 8.1 Hz, 1 H), 3.94 (d, J = 11.5 Hz, 1 H), 2.97 (d, J = 11.5 
Hz, 1 H), 2.44 (s, 3 H), 1.00 (d, J = 5.0 Hz, 1 H), 0.92 (d, J = 5.0 
Hz, 1 H), 0.47 – 0.56 (m, 1 H), 0.37 – 0.46 (m, 1 H), 0.14 (dt, J = 
5.4, 9.6 Hz, 1 H), -0.05 (m, 1 H), -0.20 (m, 1 H) ppm. 13C NMR 
(75 MHz, CDCl3) δ 143.86, 141.29, 134.86, 134.04, 130.01, 129.90, 
129.70, 128.13, 127.32, 127.05, 121.45, 115.42, 47.84, 39.64, 
24.31, 21.60, 20.43, 13.73, 2.92 ppm. HRMS (EI) calc. for 
[C22H22NO2SCl]: 399.1060, found: 399.1062.  
36a: 1H NMR (300 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz, 2 H), 7.30 (d, 
J = 8.1 Hz, 2 H), 6.87 (d, J = 5.0 Hz, 3 H), 6.38 (d, J = 8.1H z, 1 H), 
5.30 (d, J = 8.1 Hz, 1 H), 3.94 (d, J = 11.4 Hz, 1 H), 2.96 (d, J = 
11.5 Hz, 1 H), 2.43 (s, 3 H), 2.27 (s, 6 H), 1.00 (d, J = 4.8 Hz, 1 H), 
0.92 (d, J = 4.8 Hz, 1 H), 0.43 – 0.51 (m, 1 H), 0.33 – 0.42 (m, 1 H), 
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0.14 (m, 1 H), -0.07 – -0.01 (m, 1 H), -0.16 - -0.09 (m, 1 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 143.64, 139.06, 137.73, 135.07, 
129.79, 128.65, 127.69, 127.10, 121.16, 115.46, 48.17, 40.09, 
24.01, 21.57, 21.25, 20.78, 13.88, 2.75 ppm. HRMS (EI) calc. for 
[C24H27NO2S]: 393.1763, found: 393.1759. 
37a: 1H NMR (300 MHz, CDCl3) δ 7.85 (d, J = 9.5 Hz, 2 H), 7.76 (m, 
2 H), 7.63 (d, J = 8.1 Hz, 2 H), 7.41 (d, J = 5.1 Hz, 3 H), 7.28 (d, J 
= 8.2 Hz, 2 H), 6.56 (d, J = 8.2 Hz, 1 H), 5.42 (d, J = 8.1 Hz, 1 H), 
3.88 (d, J = 11.9 Hz, 1 H), 3.40 (d, J = 11.9 Hz, 1 H), 2.42 (s, 3 H), 
1.07 (s, 2 H), 0.39 - 0.43 (m, 1 H), 0.07 – 0.23 (m, 2 H), -0.41 - 
-0.24 (m, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.79, 136.58, 
134.95, 134.00, 132.05, 129.87, 128.70, 128.42, 128.07, 127.19, 
127.06, 125.87, 125.68, 125.57, 121.35, 114.34, 46.49, 38.18, 
25.26, 21.61, 21.14, 13.60, 3.12, 2.63 ppm. HRMS (EI) calc. for 
[C26H25NO2S]: 415.1606, found: 415.1608. 
38a: 1H NMR (300 MHz, CDCl3) δ 7.56 (d, J = 8.1 Hz, 2 H), 7.22 (d, 
J = 8.0 Hz, 2 H), 6.72 (s, 2 H), 6.35 (d, J = 8.1 Hz, 1 H), 5.16 (d, J 
= 8.1 Hz, 1 H), 3.74 (d, J = 12.0 Hz, 1 H), 2.84 (d, J = 12.0 Hz, 1 
H), 2.34 (s, 3 H), 2.17 (d, J = 12.1 Hz, 6 H), 2.13 (s, 3 H), 0.97 (d, 
J = 5.0 Hz, 1 H), 0.58 (d, J = 4.7Hz, 1 H), 0.42 – 0.51 (m, 1 H), 
0.25 – 0.34 (m, 1 H), 0.07 – 0.16 (m, 1 H), -0.07 (dd, J = 4.4, 9.8 
Hz, 1 H), -0.31 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.73, 
138.67, 138.55, 136.45, 135.02, 129.78, 129.56, 129.08, 127.07, 
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121.11, 114.55, 44.73, 37.46, 25.27, 22.77, 21.59, 20.85, 20.38, 
13.11, 3.65, 1.84 ppm. HRMS (EI) calc. for [C25H29NO2S]: 407.1919, 
found: 407.1921. 
39a: 1H NMR (300 MHz, CDCl3) δ 7.61 (d, J =  8.2 Hz, 2 H), 7.22 
(m, 7 H), 5.34 (s, 1 H), 4.18 (d, J = 12.8 Hz, 1 H), 3.11 (d, J = 12.8 
Hz, 1 H), 2.34 (s, 3 H), 1.86 (s, 3 H), 1.07 (d, J = 5.3 Hz, 1 H), 
0.88 (d, J = 5.2 Hz, 1 H), 0.45 – 0.54 (m, 1 H), 0.28 – 0.37 (m, 1 H), 
0.07 (m, 1 H), -0.15 (m, 1 H), -0.27 - -0.21 (m, 1 H) ppm. 13C 
NMR (75 MHz, CDCl3) δ 143.10, 139.16, 138.73, 130.03, 129.88, 
129.63, 128.31, 126.89, 126.62, 120.52, 50.46, 41.67, 24.92, 21.51, 
20.77, 18.76, 14.21, 2.98 ppm. HRMS (EI) calc. for [C23H25NO2S]: 
379.1606, found: 379.1608. 
40a: 1H NMR (300 MHz, CDCl3) δ 7.24 – 7.39 (m, 5 H), 6.23 (d, J = 
5.9 Hz, 1 H), 5.17 (d, J = 5.9 Hz, 1 H), 4.07 (d, J = 10.5 Hz, 1 H), 
3.80 (d, J = 10.5 Hz, 1 H), 1.31 (d, J = 4.5 Hz, 1 H), 1.10 (d, J = 
4.4 Hz, 1 H), 0.52 (m, 1 H), 0.39 – 0.43 (m, 1 H), 0.21 (m , 1 H), -
0.10 - -0.01 (m, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 141.55, 
138.85, 130.11, 128.27, 126.80, 109.74, 68.47, 38.76, 23.11, 20.61, 
13.77, 2.65, 2.47 ppm. HRMS (EI) calc. for [C15H16O]: 212.1201, 
found 212.1200. 
1b: 1H NMR (300 MHz, CDCl3) δ 0.89-0.98 (m, 1 H), 1.12-1.18 (m, 
2 H), 1.66-1.89 (m, 4 H), 2.31 (t, J = 9.2 Hz, 1 H), 2.52 (d, J = 
11.6 Hz, 2 H), 3.03 (t, J = 10.6 Hz, 1 H), 3.50-3.57 (m, 1 H), 4.22 
(dd, J = 9.9, 5.0 Hz, 1 H), 5.45 (d, J = 5.9 Hz, 1 H), 6.39 (d, J = 5.9 
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Hz, 1 H), 7.11-7.25 (m, 5 H) ppm. 13C NMR (75 MHz, CDCl3) δ 
25.5, 25.9, 33.9, 48.9, 53.4, 56.8, 72.1, 98.9, 124.0, 126.5, 127.77, 
127.81, 128.5, 132.7, 142.9, 145.4 ppm. HRMS (EI) calc. for 
[C18H20O]: 252.1514, found: 252.1515. 
2b: 1H NMR (300 MHz, CDCl3) δ 0.86-0.98 (m, 1 H), 1.18-1.26 (m, 
2 H), 1.70-1.88 (m, 4 H), 2.29 (t, J = 9.2 Hz, 1 H), 2.42 (s, 3 H), 
2.53-2.59 (m, 2 H), 2.63 (d, J = 11.5 Hz, 1 H), 2.77 (br s, 1 H), 
4.03 (dd, J = 10.9, 4.5 Hz, 1 H), 5.69 (d, J = 8.0 Hz, 1 H), 6.69 (d, J 
= 7.9 Hz, 1 H), 7.14 (d, J = 6.9 Hz, 2 H), 7.24-7.33 (m, 5 H), 7.60 
(d, J = 8.1 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 21.6, 25.3, 
25.6, 25.7, 33.6, 48.0, 49.5, 53.8, 57.6, 104.0, 124.6, 125.3, 126.6, 
127.0, 127.7, 128.5, 129.8, 134.9, 136.0, 142.0, 143.7 ppm. HRMS 
(EI) calc. for [C25H27NO2S]: 405.1763, found: 405.1759. 
3b: 1H NMR (300 MHz, CDCl3) δ 1.09 (s, 3 H), 1.19-1.35 (m, 3 H), 
1.76-1.91 (m, 4 H), 2.64 (d, J = 14.4,  1 H), 2.81 (br s, 1 H), 
3.16-3.20 (m, 1 H), 3.78 (dd, J = 12.3, 10.0 Hz, 1 H), 4.36 (dd, J = 
9.9, 4.7 Hz, 1 H), 5.60 (d, J = 5.8 Hz, 3 H), 6.52 (d, J = 5.8 Hz, 1 
H), 7.21 (t, J = 7.2 Hz, 1 H), 7.33 (t, J = 7.6 Hz, 2 H), 7.43 (d, J = 
7.6 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 18.6, 25.4, 25.6, 26.7, 
49.8, 51.1, 56.9, 68.7, 99.8, 122.8, 125.9, 126.1, 128.3, 130.6, 
145.4, 149.6 ppm. HRMS (EI) calc. for [C19H22O]: 266.1671, found: 
266.1668. 
4b: 1H NMR (300 MHz, CDCl3) δ 0.86-0.97 (m, 1 H), 1.16-1.26 (m, 
2 H), 1.64-1.87 (m, 4 H), 2.24 (m, 1 H), 2.42 (s, 3 H), 2.47-2.63 
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(m, 2 H), 2.59 (dd, J = 12.0, 10.8 Hz, 1 H), 2.69-2.76 (m, 1 H), 
3.81 (s, 3 H), 4.02 (dd, J = 10.8, 4.4 Hz, 1 H), 5.68 (d, J = 8.0 Hz, 
1 H), 6.69 (d, J = 8.0 Hz, 1 H), 6.84 (d, J = 8.5 Hz, 2 H), 7.06 (d, J 
= 8.5 Hz, 2 H), 7.27 (d, J = 8.2 Hz, 2 H), 7.60 (d, J = 8.2 Hz, 2 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 21.6, 25.3, 25.6, 25.7, 33.6, 48.0, 
49.6, 53.8, 55.3, 56.9, 104.0, 113.9, 124.7, 125.2, 127.0, 128.6, 
129.8, 134.0, 135.0, 136.0, 143.7, 158.3 ppm. HRMS (EI) calc. for 
[C26H29NO3S]: 435.1868, found: 435.1873. 
5b: 1H NMR (300 MHz, CDCl3) δ 0.77-0.88 (m, 1 H), 1.04-1.12 (m, 
2 H), 1.60-1.83 (m, 4 H), 2.18 (m, 1 H), 2.25 (s, 3 H), 2.32 (s, 3 
H), 2.39-2.49 (m, 2 H), 2.51 (dd, J = 11.9, 11.0 Hz, 1 H), 2.65-
2.68 (m, 1 H), 3.95 (dd, J = 11.0, 4.7 Hz, 1 H), 5.59 (d, J = 8.0 Hz, 
1 H), 6.61 (d, J = 8.0 Hz, 1 H), 6.95 (d, J = 7.9 Hz, 2 H), 7.03 (d, J 
= 7.9 Hz, 2 H), 7.18 (d, J = 8.1 Hz, 2 H), 7.51 (d, J = 8.1 Hz, 2 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 20.9, 21.5, 25.2, 25.5, 25.6, 33.5, 
47.7, 49.4, 53.7, 57.1, 103.9, 124.6, 125.1, 126.9, 127.5, 129.0, 
129.7, 134.8, 135.8, 136.0, 138.8, 143.6 ppm. HRMS (EI) calc. for 
[C26H29NO2S]: 419.1919, found: 419.1917 
6b: 1H NMR (300 MHz, CDCl3) δ 1.71 (s, 3 H), 2.42 (s, 3 H), 2.57-
2.67 (m, 3 H), 2.75-2.90 (m, 2 H), 4.06 (dd, J = 11.0, 4.3 Hz, 1 H), 
5.69 (d, J = 8.0 Hz, 1 H), 6.70 (d, J = 8.0 Hz, 1 H), 7.17 (d, J = 7.0 
Hz, 2 H), 7.23-7.33 (m, 5 H), 7.60 (d, J = 8.1 Hz, 2 H) ppm. 13C 
NMR (75 MHz, CDCl3) δ 13.6, 21.5, 46.3, 48.7, 49.4, 104.2, 125.1, 
126.6, 127.0, 127.3, 127.8, 128.5, 129.8, 130.7, 134.9, 142.7, 143.7 
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ppm. HRMS (EI) calc. for [C22H23NO2S]: 365.1449, found: 365.1451. 
7b: 1H NMR (300 MHz, CDCl3) δ 0.95 (d, J = 6.8 Hz, 3 H), 1.67 (s, 
3 H), 2.18 (dd, J = 10.9, 8.2 Hz, 1 H), 2.43 (s, 3 H), 2.48 (t, J = 
11.6 Hz, 1 H), 2.69-2.71 (m, 2 H), 3.99 (dd, J = 10.9, 4.5 Hz, 1 H), 
5.69 (d, J = 8.0 Hz, 1 H), 6.70 (d, J = 7.9 Hz, 1 H), 7.15 (d, J = 6.7 
Hz, 2 H), 7.23-7.34 (m, 5 H), 7.59 (d, J = 8.2 Hz, 2 H) ppm. 13C 
NMR (75 MHz, CDCl3) δ 11.6, 17.0, 21.6, 47.7, 49.3, 51.2, 58.8, 
104.3, 125.3, 126.7, 126.9, 127.1, 127.9, 128.4, 129.8, 134.1, 134.8, 
141.6, 143.7 ppm. HRMS (EI) calc. for [C23H25NO2S]: 379.1606, 
found: 379.1607. 
8b: 1H NMR (300MHz, CDCl3) δ 2.42 (s, 3 H), 2.68 (d, J = 11.3 Hz, 
1 H), 2.81-2.88 (m, 1 H), 3.81 (d, J = 10.3 Hz, 1 H), 3.88 (dd, J = 
11.0, 4.8 Hz, 1 H), 5.75 (s, 1 H), 5.82 (d, J = 7.9 Hz, 1 H), 6.55 (d, 
J = 7.5 Hz, 2 H), 6.65 (d, J = 7.7 Hz, 2 H), 6.86 (d, J = 7.9 Hz, 1 H), 
7.01-7.19 (m, 7 H), 7.23-7.29 (m, 4 H), 7.38 (d, J = 7.4 Hz, 2 H), 
7.58 (d, J = 8.0 Hz, 2 H) ppm. 13C NMR (75MHz, CDCl3) δ 21.6, 
45.8, 48.6, 59.1, 65.7, 105.3, 126.1, 126.4, 126.9, 127.0, 127.4, 
127.6, 127.9, 128.2, 128.3, 129.5, 129.6, 129.9, 134.6, 135.0, 138.2, 
142.9, 144.0, 147.2 ppm. HRMS (EI) calc. for [C33H29NO2S]: 
503.1919, found: 503.1916. 
9b: 1H NMR (300 MHz, CDCl3) δ 2.44 (s, 3 H), 2.65-2.71 (m, 2 H), 
2.93-3.00 (m, 1 H), 4.00 (d, J = 9.6 Hz, 1 H), 4.01-4.07 (m, 1 H), 
5.49 (s, 1 H), 5.75 (d, J = 8.0 Hz, 1 H), 6.82 (d, J = 7.9 Hz, 1 H), 
6.92-6.94 (m, 2 H), 7.01-7.03 (m, 2 H), 7.17 (d, J = 6.8 Hz, 3 H), 
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7.25 (d, J = 6.9 Hz, 3 H), 7.29 (d, J = 8.0 Hz, 2 H), 7.62 (d, J = 8.2 
Hz, 2 H) ppm.  13C NMR (75 MHz, CDCl3) δ 21.6, 48.1, 49.0, 59.3, 
61.7, 105.2, 124.6, 126.6, 126.9, 127.0, 127.4, 127.5, 127.9, 128.3, 
128.5, 130.0, 134.8, 135.7, 140.4, 143.6, 144.0 ppm. HRMS (EI) 
calc. for [C27H25NO2S]: 427.1606, found: 427.1603. 
12c: 1H NMR (300 MHz, CDCl3) δ 1.36-1.49 (m, 2 H), 1.51-1.68 
(m, 6 H), 2.23-2.42 (m, 2 H), 3.80 (d, J = 11.0 Hz, 1 H), 3.90 (d, J 
= 11.0 Hz, 1 H), 5.27 (d, J = 17.3 Hz, 1 H), 5.35 (d, J = 10.7 Hz, 1 
H), 5.81 (d, J = 6.3 Hz, 1 H), 6.20 (dd, J = 17.3, 10.6 Hz, 1 H), 6.47 
(d, J = 6.3 Hz, 1 H), 7.18-7.35 (m, 5 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 26.5, 26.7, 28.0, 30.7, 33.3, 51.1, 75.4, 103.8, 116.3, 124.7, 
126.4, 127.3, 128.4, 135.2, 139.0, 143.2, 144.4 ppm. HRMS (EI) 
calc. for [C19H22O]: 266.1671, found: 266.1672. 
13c: 1H NMR (300 MHz, CDCl3) δ 1.43-1.59 (m, 6 H), 1.83 (s, 3 H), 
1.99-2.24 (m, 3 H), 2.33-2.39 (m, 1 H), 3.17 (s, 1 H), 3.90 (dd, J 
= 10.8, 3.2  Hz, 1 H), 4.29 (dd, J = 10.8, 1.3 Hz, 1 H), 4.76 (s, 1 
H), 4.87 (s, 1 H), 5.64 (dd, J = 6.3, 0.9 Hz, 1 H), 6.37 (d, J = 6.3 
Hz, 1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 21.3, 26.9, 27.9, 28.0, 
29.5, 30.0, 43.3, 69.0, 120.6, 112.3, 120.3, 133.3, 143.7, 144.2 ppm 
HRMS (EI) calc. for [C14H20O]: 204.1514, found: 204.1512. 
14c: 1H NMR (300 MHz, CDCl3) δ 1.05-1.14 (m, 2 H), 1.34-1.61 
(m, 6 H), 2.18-2.26 (m, 1 H), 2.34-2.44 (m, 1 H), 2.40 (s, 3 H), 
2.90 (d, J = 11.6 Hz, 1 H), 3.59 (d, J = 11.4 Hz, 1 H), 5.19 (d, J = 
17.4 Hz, 1 H), 5.27 (d, J = 10.6 Hz, 1 H), 5.96 (d, J = 8.5 Hz, 1 H), 
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6.09 (dd, J = 17.3, 10.6 Hz, 1 H), 6.59 (d, J = 8.5 Hz, 1 H), 7.16-
7.21 (m, 1 H), 7.25-7.26 (m, 6 H), 7.59 (d, J = 8.2 Hz, 2 H) ppm. 
13C NMR (75 MHz, CDCl3) δ 21.6, 26.4, 26.7, 28.0, 31.2, 33.7, 50.9, 
55.5, 108.6, 117.2, 122.6, 125.5, 126.4, 127.0, 127.1, 128.4, 129.8, 
134.8, 138.5, 138.7, 143.8, 145.4 ppm. HRMS (EI) calc. for 
[C26H29NO2S]: 419.1919, found: 419.1919. 
15c: 1H NMR (300 MHz, CDCl3) δ 1.06 (br s, 2 H), 1.27-1.59 (m, 7 
H), 2.09-2.17 (m, 1 H), 2.40 (s, 3 H), 2.82 (d, J = 11.7 Hz, 1 H), 
3.46 (d, J = 11.6 Hz, 1 H), 3.70 (s, 3 H), 5.10 (d, J = 17.4 Hz, 1 H), 
5.17 (d, J = 10.6 Hz, 1 H), 5.86 (d, J = 8.5 Hz, 1 H), 6.00 (dd, J = 
17.2, 10.6 Hz, 1 H), 6.51 (d, J = 8.5 Hz, 1 H), 6.71 (d, J = 8.4 Hz, 2 
H), 7.07 (d, J = 8.5 Hz, 2 H), 7.17 (d, J = 7.8 Hz, 2 H), 7.51 (d, J = 
7.9 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 21.6, 26.4, 26.9, 28.1, 
31.3, 33.6, 50.2, 55.2, 55.5, 108.6, 113.7, 116.9, 122.5, 125.6, 
127.1, 128.0, 129.7, 134.8, 137.3, 138.7, 139.0, 143.7, 158.0 ppm. 
HRMS (EI) calc. for [C26H29NO3S]: 435.1868, found: 435.1866. 
16c: 1H NMR (300 MHz, CDCl3) δ 1.45 (br s, 6 H), 1.99-2.09 (m, 3 
H), 2.23-2.27 (m, 1 H), 2.34 (s, 3 H), 2.83 (dd, J = 11.4, 3.3 Hz, 1 
H), 3.36 (br s, 1 H), 3.82 (d, J = 11.3 Hz, 1 H), 4.84 (d, J = 10.4 Hz, 
1 H), 4.89 (d, J = 17.3 Hz, 1 H), 5.54 (ddd, J = 17.2, 10.6, 5.9Hz, 1 
H), 5.64 (d, J = 8.5 Hz, 1 H), 6.51 (d, J = 8.4 Hz, 1 H), 7.22 (d, J = 
8.1 Hz, 2 H), 7.59 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 21.6, 26.7, 27.9, 28.0, 29.8, 30.1, 38.4, 48.5, 105.8, 115.4, 
120.4, 123.1, 127.2, 129.7, 134.9, 136.1, 137.0, 143.7 ppm. HRMS 
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(EI) calc. for [C20H25NO2S]: 343.1606, found: 343.1605. 
17c: 1H NMR (300 MHz, CDCl3) δ 1.64 (d, J = 7.1 Hz, 3 H), 2.33 (s, 
3 H), 3.24 (d, J = 11.6 Hz, 1 H), 3.70 (d, J = 11.6 Hz, 1 H), 4.67 
(dd, J = 17.3, 0.6 Hz, 1 H), 4.98 (q, J = 6.9 Hz, 1 H), 5.10 (d, J = 
11.2 Hz, 1 H), 5.68 (d, J = 2.5 Hz, 1 H), 5.73 (dd, J = 14.5, 7.7 Hz, 
1 H), 6.55 (d, J = 8.3 Hz, 1 H), 7.09-7.19 (m, 7 H), 7.52 (d, J = 
8.2 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 12.9, 21.6, 50.6, 52.0, 
105.2, 117.6, 122.4, 124.4, 126.8, 127.1, 128.0, 128.4, 129.8, 133.9, 
134.9, 140.9, 140.6, 143.9 ppm. HRMS (EI) calc. for [C21H23NO2S]: 
365.1449, found: 365.1449. 
18c: 1H NMR (300 MHz, CDCl3) δ 1.02 (s, 3 H), 1.73 (s, 3 H), 2.32 
(s, 3 H), 2.87 (d, J = 11.7 Hz, 1 H), 3.52 (d, J = 11.7 Hz, 1 H), 5.04 
(d, J = 17.3 Hz, 1 H), 5.17 (d, J = 10.6 Hz, 1 H), 5.80 (d, J = 8.5 
Hz, 1 H), 5.98 (dd, J = 17.3, 10.6 Hz, 1 H), 6.51 (d, J = 8.4 Hz, 1 
H), 7.11-7.20 (m, 7 H), 7.52 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR 
(75 MHz, CDCl3) δ 21.6, 24.0, 51.0, 55.4, 109.2, 117.1, 122.2, 126.4, 
126.5, 127.2, 127.7, 128.5, 129.7, 130.4, 134.9, 138.1, 143.7, 145.0 
ppm. HRMS (EI) calc. for [C23H25NO2S]: 379.1606, found: 379.1606. 
19c: 1H NMR (300 MHz, CDCl3) δ 1.66 (d, J = 7.0 Hz, 3 H), 2.42 (s, 
3 H), 2.74 (br s, 1 H), 3.33 (ddd, J = 18.7, 11.4 , 5.7 Hz, 2 H), 5.03 
(s, 1 H), 5.08 (d, J = 7.9 Hz, 1 H), 5.12-5.16 (m, 1 H), 5.57 (ddd, J 
= 17.5, 10.2, 7.6 Hz, 1 H), 5.69 (d, J = 8.3 Hz, 1 H), 6.70 (d, J = 
8.2 Hz, 1 H), 7.31 (d, J = 8.0 Hz, 2 H), 7.67 (d, J = 8.2 Hz, 2 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 12.8, 21.6, 43.3, 48.3, 76.6, 105.2, 
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117.0, 120.1, 124.8, 127.1, 129.7, 129.9, 137.0, 143.9 ppm. HRMS 
(EI) calc. for [C16H19NO2S]: 289.1163, found: 289.1161. 
20c: 1H NMR (300 MHz, CDCl3) δ 0.41-0.46 (m, 3 H), 1.42-1.50 
(m, 2 H), 1.70 (s, 3 H), 2.31 (s, 3 H), 2.93 (d, J = 11.7 Hz, 1 H), 
3.46 (d, J = 11.7 Hz, 1 H), 5.01 (d, J = 17.3 Hz, 1 H), 5.16 (d, J = 
10.6 Hz, 1 H), 5.79 (d, J = 8.4 Hz, 1 H), 6.00 (dd, J = 17.2, 10.6 Hz, 
1 H), 6.52 (d, J = 8.4 Hz, 1 H), 7.17 (d, J = 5.8 Hz, 7 H), 7.51 (d, J 
= 8.0 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 10.8, 18.1, 21.6, 
29.5, 51.3, 55.5, 110.0, 117.1, 122.5, 126.5, 127.1, 127.2, 127.7, 
128.4, 130.0, 134.8, 135.4, 138.8, 143.8, 145.0 ppm. HRMS (EI) 
calc. for [C24H27NO2S]: 393.1762, found: 393.1762. 
21c: 1H NMR (300 MHz, CDCl3) δ 1.36 (s, 3 H), 3.88 (q, J = 11.0 
Hz, 2 H), 5.27-5.39 (m, 3 H), 6.24 (dd, J = 17.0, 11.0 Hz, 2 H), 
7.18 (t, J = 7.5 Hz, 4 H), 7.26-7.33 (m, 4 H), 7.38 (d, J = 7.5 Hz, 2 
H) ppm. 13C NMR (75 MHz, CDCl3) δ 23.4, 50.9, 75.3, 106.3, 117.0, 
126.6, 126.7, 127.4, 128.2, 128.3, 128.6, 128.7, 128.9, 129.7, 137.8, 
143.2, 143.6 ppm. HRMS (EI) calc. for [C21H20O]: 288.1514, found: 
288.1514. 
22c: 1H NMR (300 MHz, CDCl3) δ 2.72 (ddd, J = 23.5, 16.6, 7.5 Hz, 
2 H), 3.87 (q, J = 11.0 Hz, 2 H), 5.32 (d, J = 12.3 Hz, 1 H), 5.41 
(dd, J = 14.1, 7.7 Hz, 2 H), 6.61 (dd, J = 17.3, 10.6 Hz, 1 H), 6.36 
(d, J = 5.9 Hz, 1 H), 6.85 (d, J = 7.1 Hz, 2 H), 7.08 (dd, J = 15.2, 
7.3 Hz, 2 H), 7.14-7.19 (m, 2 H), 7.25 (t, J = 7.4 Hz, 2 H), 7.34 (d, 
J = 7.3 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 35.6, 50.9, 74.7, 
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109.2, 117.1, 125.9, 126.2, 127.0, 127.8, 128.3, 128.6, 133.9, 138.3, 
140.9, 142.6, 143.4 ppm. HRMS (EI) calc. for [C21H20O]: 288.1514, 
found: 288.1514. 
23c: 1H NMR (300 MHz, CDCl3) δ 1.18-1.52 (m, 8 H), 1.63 (d, J = 
5.8 Hz, 3 H), 2.15-2.18 (m, 1 H), 2.27-2.30 (m, 1 H), 2.330 (s, 3 
H), 2.85 (d, J = 11.7 Hz, 1 H), 3.45 (d, J = 11.7 Hz, 1 H), 5.48 (q, J 
= 6.0 Hz, 1 H), 5.57 (d, J = 16.0 Hz, 1 H), 5.86 (d, J = 8.5 Hz, 1 H), 
6.52 (d, J = 8.5 Hz, 1 H), 7.08-7.12 (m, 1 H), 7.16-7.19 (m, 6 H), 
7.52 (d, J = 8.2 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3) δ 18.4, 
21.6, 26.5, 26.7, 28.0, 31.2, 33.7, 50.1, 55.8, 108.4, 122.5, 126.2, 
126.3, 127.1, 127.5, 128.3, 129.7, 131.6, 135.0, 138.1, 143.6, 146.1 
ppm. HRMS (EI) calc. for [C27H32NO2S]: 433.2075, found: 433.2075. 
26d: 1H NMR (300 MHz, CDCl3) δ 7.42 (d, J = 8.1 Hz, 2 H), 7.15 – 
7.17 (m, 7 H), 6.44 (d, J = 8.0 Hz, 1 H), 5.71 (t, J = 3.7 Hz, 1 H), 
5.49 (d, J = 8.1 Hz, 1 H), 4.26 (d, J = 11.6 Hz, 1 H), 2.83 (d, J = 
11.6 Hz, 1 H), 2.39 (s, 3 H), 2.14 (dd, J = 3.5, 7.7 Hz, 2 H), 1.82 – 
1.87 (m, 1 H), 1.41 – 1.51 (m, 2 H), 1.26 – 1.27 (d, J = 4.5 Hz, 1 H) 
ppm. 13C NMR (75 MHz, CDCl3) δ 143.42, 142.53, 135.25, 132.73, 
129.61, 127.97, 127.40, 126.89, 126.21, 124.43, 123.80, 109.76, 
54.28, 42.17, 34.81, 25.52, 21.52, 17.51 ppm. HRMS (EI) calc. for 
[C22H23NO2S]: 365.1450, found: 365.1446. 
27d: 1H NMR (300 MHz, CDCl3) δ 7.42 (d, J = 8.1 Hz, 2 H), 7.16 (d, 
J = 8.0 Hz, 2 H), 7.04 (d, J = 8.0 Hz, 2 H), 6.96 (d, J = 8.1 Hz, 2 H), 
6.45 (d, J = 8.0 Hz, 1 H), 5.69 (t, J = 3. 6 Hz, 1 H), 5.48 (d, J = 8.0 
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Hz, 1 H), 4.23 (d, J = 11.6 Hz, 1 H), 2.82 (d, J = 11.6 Hz, 1 H), 
2.39 (s, 3 H), 2.29 (s, 3 H), 2.11 – 2.14 (m, 2 H), 1.82 (td, J = 3.6, 
5.5 Hz, 1 H), 1.39 – 1.48 (m, 2 H), 1.25 (t, J = 11.3 Hz, 1 H) ppm. 
13C NMR (75 MHz, CDCl3) δ 143.29, 139.46, 135.68, 135.39, 132.88, 
129.51, 128.64, 127.24, 126.88, 124.28, 123.72, 109.78, 54.34, 
41.82, 34.77, 25.53, 21.56, 20.99, 17.55 ppm. HRMS (EI) calc. for 
[C23H25NO2S]: 379.1606, found: 379.1604. 
28d: 1H NMR (300 MHz, CDCl3) δ 7.35 (d, J = 8.3 Hz, 2 H), 7.08 (d, 
J = 8.0 Hz, 2 H), 6.98 (d, J = 8.9 Hz, 2 H), 6.61 (d, J = 8.9 Hz, 2 H), 
6.40 (d, J = 8.0 Hz, 1 H), 5.61 (t, J = 3.8 Hz, 1 H), 5.41 (d, J = 8.1 
Hz, 1 H), 4.12 (d, J = 11.6 Hz, 1 H), 3.70 (s, 3 H), 2.76 (d, J = 11.7 
Hz, 1 H), 2.32 (s, 3 H), 2.06 (dd, J = 3.9, 8.1 Hz, 2 H), 1.07 – 1.75 
(m, 1 H), 1.32 – 1.43 (m, 2 H), 1.19 – 1.20 (m, 1 H) ppm. 13C NMR 
(75 MHz, CDCl3) δ 157.96, 143.34, 135.47, 134.36, 132.96, 129.53, 
128.39, 126.82, 124.28, 123.71, 113.25, 109.77, 55.08, 54.44, 
41.51, 34.76, 25.54, 21.50, 17.52 ppm. HRMS (EI) calc. for 
[C23H25NO3S]: 395.1555, found: 395.1552. 
29d: 1H NMR (300 MHz, CDCl3) δ 7.39 (d, J = 8.3 Hz, 2 H), 7.16 (d, 
J = 8.1 Hz, 2 H), 7.00 – 7.06 (m, 4 H), 6.53 (d, J = 8.0 Hz, 1 H), 
5.72 (t, J = 3.7 Hz, 1 H), 5.50 (d, J = 8.0 Hz, 1 H), 4.16 (d, J = 
12.0 Hz, 1 H), 2.93 (d, J = 12.0 Hz, 1 H), 2.43 (s, 3 H), 2.11 – 2.15 
(m, 2 H), 1.79 – 1.84 (m, 1 H), 1.43 – 1.52 (m, 2 H), 1.10 – 1.19 (m, 
59 
 
1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.62, 141.16, 135.56, 
132.34, 132.17, 129.56, 128.83, 127.96, 126.64, 124.72, 123.91, 
109.39, 54.35, 41.85, 34.50, 25.46, 21.61, 17.49 ppm. HRMS (EI) 
calc. for [C22H22NO2SCl]: 399.1060, found: 399.1062. 
30d: 1H NMR (300 MHz, CDCl3) δ 7.34 (d, J = 8.2 Hz, 2 H), 7.08 (d, 
J = 8.1 Hz, 2 H), 7.00 (dd, J = 5.4, 8.7 Hz, 2 H), 6.71 (t, J = 8.7 Hz, 
2 H), 6.43 (d, J = 8.0 Hz, 1 H), 5.62 (t, J = 3.7 Hz, 1 H), 5.42 (d, J 
= 8.0 Hz, 1 H), 4.10 (d, J = 11.7 Hz, 1 H), 2.80 (d, J = 11.8 Hz, 1 
H), 2.32 (s, 3 H), 2.04 – 2.07 (m, 2 H), 1.72 – 1.76 (m, 1 H), 1.34 – 
1.43 (m, 2 H), 1.05 – 1.18 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3) 
δ 143.56, 135.52, 132.63, 129.58, 129.03, 128.92, 126.73, 124.57, 
123.88, 114.77, 114.49, 109.55, 54.47, 41.72, 34.69, 25.47, 21.45, 
17.45 ppm. HRMS (EI) calc. for [C22H22NO2FS]: 383.1355, found: 
383.1353. 
31d: 1H NMR (300 MHz, CDCl3) δ 7.32 (d, J = 8.3, Hz, 2 H), 7.28 (d, 
J = 8.8 Hz, 2 H), 7.16 (d, J = 8.3 Hz, 2 H), 7.06 (d, J = 8.1 Hz, 2 H), 
6.44 (d, J = 8.0 Hz, 1 H), 5.67 (t, J = 3.6 Hz, 1 H), 5.43 (d, J = 8.1 
Hz, 1 H), 4.16 (d, J = 11.9 Hz, 1 H), 2.87 (d, J = 11.9 Hz, 1 H), 
2.29 (s, 3 H), 2.05 – 2.08 (m, 2 H), 1.75 – 1.79 (m, 1 H), 1.32 - 
1.51 (m, 2 H), 0.98 – 1.11 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3) 
δ 143.71, 135.40, 132.09, 129.58, 127.82, 126.70, 124.91, 124.83, 
124.78, 124.73, 124.00, 109.24, 54.14, 42.30, 34.58, 25.40, 21.36, 




32d: 1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 8.2 Hz, 2 H), 7.12 – 
7.16 (m, 4 H), 7.03 (d, J = 8.4 Hz, 2 H), 6.33 (d, J = 8.0 Hz, 1 H), 
5.62 (t, J = 3.6 Hz, 1 H), 5.40 (d, J = 8.1 Hz, 1 H), 4.21 (d, J = 
11.3 Hz, 1 H), 2.69 (d, J = 11.4 Hz, 1 H), 2.32 (s, 3 H), 2.05 – 2.07 
(m, 2 H), 1.70 – 1.75 (m, 1 H), 1.32 – 1.43 (m, 2 H), 1.23 (s, 9 H), 
1.23 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 148.82, 143.37, 
139.30, 135.08, 132.88, 129.62, 127.09, 126.98, 124.81, 124.15, 
123.70, 109.76, 71.35, 54.00, 42.63, 41.74, 35.02, 34.27, 31.43, 
25.53, 21.57, 17.52 ppm. HRMS (EI) calc. for [C26H31NO2S]: 
421.2076, found: 421.2079. 
33d: 1H NMR (300 MHz, CDCl3) δ 7.33 (d, J = 8.2 Hz, 2 H), 7.07 (d, 
J = 8.1 Hz, 2 H), 6.98 (d, J = 7.7 Hz, 1 H), 685 – 6.90 (m, 3 H), 
6.39 (d, J = 8.0 Hz, 1 H), 5.62 (t, J = 3.6 H, 1 H), 5.43 (d, J = 8.1 
Hz, 1 H), 4.16 (d, J = 11.6 Hz, 1 H), 2.77 (d, J = 11.6 Hz, 1 H), 
2.31 (s, 3 H), 2.17 (s, 3 H), 2.04 – 2.07 (m, 2 H), 1.75 – 1.80 (m, 1 
H), 1.32 – 1.42 (m, 2 H), 1.13 – 1.20 (m, 1 H) ppm. 13C NMR (75 
MHz, CDCl3) δ 143.27, 142.57, 137.21, 135.38, 132.83, 129.51, 
128.01, 127.79, 127.02, 126.79, 124.60, 124.40, 123.70, 109.90, 
54.48, 42.07, 34.79, 25.55, 21.67, 21.52, 17.58 ppm. HRMS (EI) 
calc. for [C23H25NO2S]: 379.1606, found: 379.1607. 
34d: 1H NMR (300 MHz, CDCl3) δ 7.35 (d, J = 8.2 Hz, 2 H), 7.00 – 
7.09 (m, 3 H), 6.71 (d, J = 7.5 Hz, 1 H), 6.59 (d, J = 7.5 Hz, 2 H), 
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6.40 (d, J = 8.0 Hz, 1 H), 5.62 (t, J = 3.5 Hz, 1 H), 5.42 (d, J = 8.0 
Hz, 1 H), 4.16 (d, J = 11.6 Hz, 1 H), 3.66 (s, 3 H), 2.76 (d, J = 11.6 
Hz, 1 H), 2.30 (s, 3 H), 2.05 – 2.06 (m, 2 H), 1.79 (dd, J = 3.5, 12.7 
Hz, 1 H), 1.32 – 1.41 (m, 2 H), 1.19 (dd, J = 8.7, 11.6 Hz, 1 H) ppm. 
13C NMR (75 MHz, CDCl3) δ 159.14, 144.40, 143.36, 135.31, 132.74, 
129.56, 128.88, 126.81, 124.50, 123.74, 119.74, 114.04, 111.13, 
109.81, 55.03, 54.37, 42.22, 34.67, 25.51, 21.53, 17.55 ppm. HRMS 
(EI) calc. for [C23H25NO3S]: 395.1555, found: 395.1559. 
35d: 1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 8.2 Hz, 2 H), 7.16 (d, 
J = 8.1 Hz, 2 H), 7.03 – 7.07 (m, 4 H), 6.52 (d, J = 8.0 Hz, 1 H), 
5.72 (t, J = 3.7 Hz, 1 H), 5.51 (d, J = 8.1 Hz, 1 H), 4.16 (d, J = 
11.8 Hz, 1 H), 2.90 (d, J = 11.9 Hz, 1 H), 2.39 (s, 3 H), 2.12 – 2.15 
(m, 2 H), 1.81 – 1.86 (m, 1 H), 1.42 – 1.52 (m, 2 H), 1.11 – 1.22 (m, 
1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 145.07, 143.52, 135.31, 
133.80, 132.14, 129.61, 129.26, 127.90, 126.67, 126.46, 125.49, 
124.92, 123.93, 109.51, 54.35, 42.18, 34.55, 25.44, 21.55, 17.49 
ppm. HRMS (EI) calc. for [C22H22NO2SCl]: 399.1060, found: 
399.1062. 
36d: 1H NMR (300 MHz, CDCl3) δ 7.40 (d, J = 8.2 Hz, 2 H), 7.15 (d, 
J = 8.1 Hz, 2 H), 6.74 (m + s, 3 H), 6.51 (d, J = 8.0 Hz, 1 H), 5.71 
(t, J = 3.4 Hz, 1 H), 5.54 (d, J = 8.0 Hz, 1 H), 4.24 (d, J = 11.7 Hz, 
1 H), 2.89 (d, J = 11.7 Hz, 1 H), 2.40 (s, 3 H), 2.23 (s, 6 H), 2.14 – 
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2.17 (m, 2 H), 1.86 – 1.91 (m, 1 H), 1.40 – 1.49 (m, 2 H), 1.30 (br s, 
1 H) ppm. 13C NMR (75 MHz, CDCl3) δ 143.12, 142.62, 136.98, 
135.56, 132.96, 129.35, 127.98, 126.68, 125.24, 124.38, 123.60, 
110.07, 54.72, 41.98, 34.74, 25.58, 21.52, 17.64, 1.04 ppm. HRMS 
(EI) calc. for [C24H27NO2S]: 393.1763, found: 393.1765. 
39d: 1H NMR (300 MHz, CDCl3) δ 7.21 – 7.27 (m, 5 H), 6.91 – 6.98 
(m, 4 H), 5.54 (t, J = 3.5 Hz, 1 H), 5.24 (s, 1 H), 4.78 (d, J = 12.2 
Hz, 1 H), 3.13 (d, J = 12.2 Hz, 1 H), 2.26 (s, 3 H), 2.08 – 2.10 (m, 2 
H), 1.91 (dd, J = 3.1, 12.0 Hz, 1 H), 1.73 (s, 3 H), 1.47 (t, J = 5.6 
Hz, 2 H), 1.42 (dd, J = 6.1, 9.1Hz, 1 H) ppm. 13C NMR (75 MHz, 
CDCl3) δ 143.13, 144.00, 138.73, 134.46, 132.83, 129.49, 128.22, 
128.16, 126.94, 126.42, 122.38, 111.29, 56.57, 42.75, 34.26, 25.40, 
21.43, 20.94, 17.75 ppm. HRMS (EI) calc. for [C23H25NO2S]: 
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염화 백금 촉매를 이용한 고리화 반응, 열적 재배열반응 그리고 로듐(I) 
촉매를 이용한 재배열 반응으로 1,6-인아인으로부터 다양한 분자 구조
를 합성해낼 수 있었다. 이러한 반응에 의해 일반적인 1,6-인아인으로부
터 1-아릴-테트라하이드로-1H-인덴, 3-메틸렌-4-바이닐사이클로헥
센, 그리고 아릴-헥사하이드로아이소퀴놀린이 생성됨을 관찰하였다; 인
아인의 치환기와 연결기에 따라 염화 백금을 이용한 고리화 반응에 의한 
생성물, 바이사이클로[4.1.0]헵텐은 바이닐사이클로프로판-사이클로펜텐 
재배열, 1,5-수소 재배열, 그리고 새로운 고리화 반응이 진행되었다. 
 
주요어 : 염화 백금, 로듐, 바이사이클로[4.1.0]헵텐, 싸이클로프로판, 재
배열 
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